<!DOCTYPE html>
<html>
<head>
    <meta charset="utf-8" />
    <!-- Website Design By: www.happyworm.com -->
    <title>E Module</title>
    <!-- fonticon -->
    <link href="../common/css/font-awesome.css" rel="stylesheet" />
    <!-- textillate -->
    <link href="../common/css/animate.css" rel="stylesheet">
    <link href="../common/css/style.css" rel="stylesheet">
    <link href="../common/css/table.css" rel="stylesheet">
    <link href="../common/css/bluetable.css" rel="stylesheet">
    <!-- bootstrap -->
    <link rel="stylesheet" href="../common/css/bootstrap.min.css">
    <link rel="stylesheet" href="../common/css/bootstrap-theme.min.css">
    <link href="../common/css/sticky-footer.css" rel="stylesheet">
    <!-- slide bar -->
    <link href="../common/css/mbExtruder.css" media="all" rel="stylesheet" type="text/css">
    <!-- custom styles -->
    <link href="../common/css/common.css" media="all" rel="stylesheet" type="text/css">
    <!-- jquery Slider -->
    <link href="../common/css/simple-slider.css" rel="stylesheet" type="text/css" />
    <link href="../common/css/simple-slider-volume.css" rel="stylesheet" type="text/css" />
    <!-- tooltip -->
    <link href="../common/css/tipsy.css" rel="stylesheet" type="text/css" />
    <!-- image efect -->
    <link rel="stylesheet" href="../common/css/hoverEx.css" />
    <!-- jquery dropdown -->
    <link type="text/css" rel="stylesheet" href="../common/css/jquery.dropdown.css" />
    <!-- scripts-->
    <!-- Latest compiled and minified JavaScript -->

    <script type="text/javascript" src="../common/js/jquery-1.9.1.js"></script>

    <script type="text/javascript" src="../common/js/jquery-ui.js"></script>

    <script type="text/javascript" src="../common/js/jquery.dropdown.js"></script>

    <!-- simple slider -->

    <script src="../common/js/simple-slider.js"></script>

    <!-- bootstrap -->

    <script src="../common/js/bootstrap.min.js"></script>

    <!-- slide bar -->

    <script type="text/javascript" src="../common/js/jquery.hoverIntent.min.js"></script>

    <script type="text/javascript" src="../common/js/jquery.mb.flipText.js"></script>

    <script type="text/javascript" src="../common/js/mbExtruder.js"></script>

    <!-- textillate -->

    <script src="../common/js/jquery.fittext.js"></script>

    <script src="../common/js/jquery.lettering.js"></script>

    <script src="../common/js/jquery.textillate.js"></script>

    <!-- tooltip -->

    <script src="../common/js/jquery.tipsy.js"></script>

    <!-- course player -->

    <script src="../common/js/player/CoursePlayer.js"></script>

    <script src="../common/js/player/TrackerService.js"></script>

    <script src="../common/js/custom.js"></script>

    <script src="../common/js/jquery.zoom.js"></script>

    <style>
        .border img {
            -webkit-box-shadow: 0 8px 6px -6px black;
            -moz-box-shadow: 0 8px 6px -6px black;
            box-shadow: 0 8px 6px -6px black;
            padding: 4px;
            background-color: rgba(204, 204, 204, 0.61);
            border-radius: 7px;
            margin-bottom: 10px;
        }
    </style>

    <script type="text/javascript">
        $(function () {
            $("#extruderLeft2").buildMbExtruder({
                position: "left",
                width: 200,
                positionFixed: false,
                top: 125,
                extruderOpacity: .8,
                onExtOpen: function () { },
                onExtContentLoad: function () { },
                onExtClose: function () { }
            });
        });

        function PlayEvents() {
        }
        PlayEvents.prototype.onAudioFailed = function () {
            alert("Failed to load audio.");
        }

        var coursePlayer = null;

        function Init() {
            coursePlayer = new CoursePlayer("moduleAudio", new PlayEvents());
            coursePlayer.initialize("Adcetris_Module_6_WSB_Ver_4.02.xml");
            coursePlayer.play();
        }

        function onLoadSlidebyID(ID) {
            coursePlayer.LoadbySlide(ID);
        }

        function Next() {
            if (disableAll)
                return;
            if (coursePlayer.nextSlide())
                coursePlayer.play();
        }
        function Prev() {
            if (disableAll)
                return;
            if (coursePlayer.prevSlide())
                coursePlayer.play();
        }

        function play() {
            if (disableAll)
                return;

            if (!coursePlayer.getPlayerStatus()) {
                document.getElementById("toggelbutton").src = "../common/img/pauseBtn.png";
                coursePlayer.play();
            }
            else {

                document.getElementById("toggelbutton").src = "../common/img/playBtn.png";
                coursePlayer.pause();
            }
        }




        //]]>
    </script>

    <style type="text/css">
        .left {
            float: left;
            display: inline;
        }

        .right {
            float: left;
            ;
            display: inline;
        }

        .graph {
        }

        .slidecontent img:not(.noStyle) {
            -webkit-box-shadow: 0 8px 6px -6px black;
            -moz-box-shadow: 0 8px 6px -6px black;
            box-shadow: 0 8px 6px -6px black;
            padding: 4px;
            background-color: rgba(204, 204, 204, 0.61);
            border-radius: 7px;
            margin-bottom: 10px;
        }

        .popupView {
            position: absolute;
            border-bottom: 138px;
            border-right: 47px;
            border-left: 36px;
            border-top: 155px;
            border-style: solid;
            border-color: rgba(179, 221, 230, 0.79);
            border-radius: 5px;
            width: 670px;
            height: 545px;
            z-index: 123;
        }
    </style>
</head>
<body style="overflow-x: hidden; font-family: Verdana" onload="createAttempt();">
    <div id="wrap" style="width: 1024px;">
        <div class="" style="height: 90px;">
            <div class="header-top">
            </div>
            <div class="header-body">
                <img src="../common/img/logo.png" class="logo" />
                <div class="header-help">
                    <h3 id="slideTitle" style="max-width: 60%; font-size: 18px;" class="module-title">
                    </h3>
                    <div style="float: right">
                        <img class="effect" onmouseover="HideToolTip(this)" onclick="onclickPlaylistImg()"
                            data-toggle="tooltip" data-placement="left" title="Playlist" style="float: left;
                            opacity: 0.7; width: 36px; margin-top: 14px; margin-right: 8px;" src="../common/img/content.png" />
                        <img class="effect" onmouseover="HideToolTip(this)" data-horizontal-offset="-10"
                            data-dropdown="#dropdown-6" data-toggle="tooltip" data-placement="bottom" title="Reference"
                            style="float: left;" src="../common/img/smallicon1.png" />
                        <img class="effect" onmouseover="HideToolTip(this)" onclick="onclickGlossaryImg()"
                            data-toggle="tooltip" data-placement="customTooltip" title="Glossary" style="float: left;
                            margin-right: 40px;" src="../common/img/smallicon4.png" />
                        <img class="headerleftbg" src="../common/img/headerCorBg.png" />
                    </div>
                </div>
                <div id="dropdown-6" class="dropdown dropdown-tip dropdown-anchor-right has-icons">
                    <div class="dropdown-panel">
                    </div>
                </div>
            </div>
            <audio id="moduleAudio"></audio>
        </div>
        <div style="position: relative; height: 615px;">
            <!--<div id="extruderLeft2" class="a {title:'Slides\'s', url:'parts/extruderLeft.html'}">
                <div class="playlist" style="height: 615px;">
                    <div class="playlist-header"></div>
                    <div id="playlist" class="playlist-item">
                        <div class="list-items">title <span>0:00</span></div>
                    </div>
                    <div class="playlist-footer">
                        <p>Total Duration : <span id="totalDuration">00:00</span></p>
                    </div>
                </div>

            </div>-->
            <div class="slidePlayer">
                <div id="PlayListDiv" style="display: none;">
                    <div class="coursecontent" style="height: 600px; width: 100%;">
                        <div class="playlist-header">
                            <button type="button" class="header-close" onclick="onclickClosePlaylist()" style="float: right;">
                                close</button>
                        </div>
                        <div id="playlist" class="playlist-item  style-5">
                            <div class="list-items">
                                title <span>0:00</span>
                            </div>
                        </div>
                        <div class="playlist-footer">
                            <p>
                                Total Duration : <span id="totalDuration">00:00</span>
                            </p>
                        </div>
                    </div>
                </div>
                <div id="GlossaryDiv" style="display: none;">
                    <div class="coursecontent" style="height: 600px; width: 100%;">
                        <div class="playlist-header">
                            <button type="button" class="header-close" onclick="onclickCloseglossary()" style="float: right;">
                                Close</button>
                        </div>
                        <div id="Div2" class="playlist-item  style-5">
                            <div id="GlossaryTitle" class="GlossaryTitle style-5">
                            </div>
                            <div id="GlossaryData" class="GlossaryData style-5">
                            </div>
                        </div>
                        <div class="playlist-footer">
                        </div>
                    </div>
                </div>
                <div id="slide0a" style="display: none;">
                    <!-- <div class="topic-bar">
                        <div id="topic-title">Title</div>
                    </div>-->
                    <!--Body -->
                    <div style="height: 550px; width: 100%; float: left; border: 2px solid rgba(127, 145, 145, 0.12);
                        border-radius: 10px; background-color: rgba(255, 255, 255, 0.2);">
                        <div class="playBody">
                            <div data-class="fadeInDown" class="breakout" style="display: none; margin-left: 30px;
                                margin-top: 250px; text-align: center;" id="s0abimg1">
                                <p style="padding-left: 40px; font-size: 20px;">
                                    Overview of Clinical Publications of Pivotal Trials in HL and sALCL
                                </p>
                            </div>
                        </div>
                    </div>
                    <!--Transcript -->
                    <!--<div onclick="onclickShowTranscription(this);" id="stickyContent" style="display: none;
                        position: absolute; right: 0; margin-top: 184px;">
                        <a href="#">
                            <img src="../common/img/showTrans.png" /></a>
                    </div>
                    <div id="transcript-hide" style="display: none;">
                        <center>
                            <button type="button" class="hidebutton" onclick="onclickHideTranscription(this);">
                                Hide Transcript</button></center>
                        <div class="transcript">
                           
                        </div>
                    </div>
                    <div id="slide0aref" style="display: none;" class="slide0aref">
                        <b>References:</b><br />
                        <br />
                       
                    </div>-->
                </div>
                <div id="slide0b" style="display: none;">
                    <!--  <div class="topic-bar">
                    <div id="topic-title">Second Frame</div>
                </div>-->
                    <div style="height: 550px; width: 100%; float: left; border: 2px solid rgba(127, 145, 145, 0.12);
                        border-radius: 10px; background-color: rgba(255, 255, 255, 0.2);">
                        <div class="playBody">
                            <div style="padding-left: 84px; padding-top: 10px;">
                                <img id="txt1" data-class="fadeInDown" src="img/slide2txt1.png" style="display: none;
                                    cursor: pointer;" onclick="Next();" class="border" />
                            </div>
                            <div style="float: left; margin-top: 24px;">
                                <img data-class="fadeInDown" id="img1" class="border" src="img/slide2img1.png" style="display: none;
                                    width: 430px; margin: 20px; cursor: pointer;" onclick="Next();" />
                            </div>
                            <div style="margin-top: -47px; float: right; margin-right: 83px;">
                                <img id="txt2" data-class="fadeInDown" src="img/slide2txt2.png" class="border" style="display: none;
                                    cursor: pointer;" onclick="onLoadSlidebyID(17);" />
                            </div>
                            <div style="text-align: center; float: right; margin-top: 24px;">
                                <img data-class="fadeInDown" id="img2" src="img/slide2img2.png" class="border" style="display: none;
                                    width: 430px; cursor: pointer; margin: 20px;" onclick="onLoadSlidebyID(17);" />
                            </div>
                        </div>
                        <!-- <div style="text-align: center; float: right; margin-top: 24px;">
                            <img data-class="fadeInDown" id="img2" src="img/slide2img2.png" class="border" style="display: none; width: 482px; cursor: pointer;"
                                onclick="onLoadSlidebyID(17);" />
                        </div>-->
                    </div>
                </div>
                <!--<div onclick="onclickShowTranscription(this);" id="stickyContent" style="display: none;
                            position: absolute; right: 0; margin-top: 184px;">
                            <a href="#">
                                <img src="img/showTrans.png" /></a>
                        </div>
                        <div id="transcript-hide" style="display: none;">
                            <center>
                                <button type="button" class="hidebutton" onclick="onclickHideTranscription(this);">
                                    Hide Transcript</button></center>
                            <div class="transcript" style="">
                                
                            </div>
                        </div>
                        <div id="slide0bref" style="display: none" class="slide0bref">
                            <b>References:</b><br />
                            <br />
                            Brentuximab Vedotin (SGN-35) in Patients With Relapsed or Refractory Systemic Anaplastic
                            Large-Cell Lymphoma: Results of a Phase II Study. Pro et al. Journal Of Clinical
                            Oncology. June 2012.
                        </div>-->
                <div id="slide0" style="display: none;">
                    <!--Body -->
                    <!--<div class="topic-bar">
                        <div id="topic-title">Learning objectives</div>
                     </div>-->
                    <div id="slide0ref" style="display: none;" class="slide0ref">
                        <b>References:</b>
                        <br />
                        Results of a Pivotal Phase II Study of Brentuximab Vedotin for Patients With Relapsed
                        or Refractory Hodgkin’s Lymphoma. Younes et al. Journal Of Clinical Oncology. June
                        2012.
                    </div>
                    <div class="slidecontent" style="">
                        <div class="playBody" style="text-align: center; margin-top: 25px;">
                            <div data-class="fadeInDown" id="bimg1" style="display: none;">
                                <img src="../common/img/bullet01.png" class="noStyle" class="noStyle" style="width: 12px;
                                    height: 12px; float: left; margin: 10px;" />
                                <p style="text-align: left;">
                                    This module is a part of an e-learning program strictly for internal training purposes
                                    only
                                </p>
                            </div>
                            <br />
                            <div id="bimg2" style="display: none;" data-class="fadeInDown">
                                <img src="../common/img/bullet01.png" class="noStyle" class="noStyle" style="width: 12px;
                                    height: 12px; float: left; margin: 10px;" />
                                <p style="text-align: left;">
                                    At the end of this module you should
                                </p>
                                <br />
                            </div>
                            <div style="padding-left: 40px">
                                <div data-class="fadeInDown" id="bimg3" style="display: none;">
                                    <img src="../common/img/bullet01.png" class="noStyle" class="noStyle" style="width: 12px;
                                        height: 12px; float: left; margin: 10px;" />
                                    <p style="padding-left: 30px; text-align: left;">
                                        Be acclimatized with the pivotal phase II trial of brentuximab vedotin in individuals
                                        with relapsed or refractory Hodgkin's lymphoma after high-dose chemotherapy and autologous
                                        stem-cell transplantation and in patients with relapsed or refractory systemic anaplastic
                                        large-cell lymphoma
                                    </p>
                                    <br />
                                </div>
                                <div data-class="fadeInDown" style="display: none;" id="bimg4">
                                    <img src="../common/img/bullet01.png" class="noStyle" class="noStyle" style="width: 12px;
                                        height: 12px; float: left; margin: 10px;" />
                                    <p style="padding-left: 30px; text-align: left;">
                                        Understand the mechanism of action of brentuximab vedotin and its role in management of relapsed or refractory Hodgkin's Lymphoma and relapsed or refractory systemic anaplastic large-cell lymphoma
                                    </p>
                                    <br />
                                </div>
                                <div data-class="fadeInDown" id="bimg5" style="display: none;">
                                    <img src="../common/img/bullet01.png" class="noStyle" class="noStyle" style="width: 12px;
                                        height: 12px; float: left; margin: 10px;" />
                                    <p style="padding-left: 30px; text-align: left;">
                                        Be aware of the key components of the trial including the materials and methods,
                                        results and conclusions
                                    </p>
                                </div>
                            </div>
                        </div>
                    </div>
                    <!--Transcript -->
                    <div onclick="onclickShowTranscription(this);" id="stickyContent" style="display: none;
                        position: absolute; right: 0; margin-top: 184px;">
                        <a href="#">
                            <img src="../common/img/showTrans.png" /></a>
                    </div>
                    <div id="transcript-hide" style="display: none;">
                        <center>
                            <button type="button" class="hidebutton" onclick="onclickHideTranscription(this);">
                                Hide Transcript</button></center>
                        <div class="transcript" style="">
                            <p>
                                This module is a part of an e-learning program which focuses on the different aspects
                                of brentuximab vedotin, pivotal clinical trials with brentuximab vedotin, role and
                                approval for use in certain patient populations which include patients with relapsed
                                or refractory Hodgkin's Lymphoma and patients with relapsed or refractory systemic
                                anaplastic large-cell lymphoma. The material presented as part of this e-learning
                                program is strictly for internal training purposes only.
                            </p>
                            <p>
                                At the end of this module you should be acclimatized with the pivotal phase II trials
                                of brentuximab vedotin in individuals with relapsed or refractory Hodgkin’s lymphoma
                                after high-dose chemotherapy and autologous stem-cell transplantation and in patients
                                with relapsed or refractory systemic anaplastic large-cell lymphoma.
                            </p>
                            <p>
                                You should understand the mechanism of action of brentuximab vedotin and its role
                                in management of relapsed or refractory Hodgkin’s Lymphoma and relapsed or refractory
                                systemic anaplastic large-cell lymphoma.
                            </p>
                            <p>
                                You should be aware of the key components of the trials including the materials
                                and methods, results and conclusions.
                            </p>
                        </div>
                    </div>
                </div>
                <div id="slide1a" style="display: none;">
                    <!-- <div class="topic-bar">
                        <div id="topic-title">HL: survival rates</div>
                    </div>-->
                    <!--Body -->
                    <div class="slidecontent" style="">
                        <div class="playBody">
                            <div class="fadeInDown" style="display: none" id="s1abimg1">
                                <p class="breakout" style="padding-left: 40px;">
                                    Results of a Pivotal Phase II Study of Brentuximab Vedotin for Patients With Relapsed
                                    or Refractory Hodgkin’s Lymphoma. Younes et al. Journal Of Clinical Oncology. June
                                    2012
                                </p>
                            </div>
                        </div>
                    </div>
                    <!--Transcript -->
                    <div onclick="onclickShowTranscription(this);" id="stickyContent" style="display: none;
                        position: absolute; right: 0; margin-top: 184px;">
                        <a href="#">
                            <img src="../common/img/showTrans.png" /></a>
                    </div>
                    <div id="transcript-hide" style="display: none;">
                        <center>
                            <button type="button" class="hidebutton" onclick="onclickHideTranscription(this);">
                                Hide Transcript</button></center>
                        <div class="transcript">
                            <p>
                                The following part of the module will discuss the key points of the paper titled
                                'Results of a Pivotal Phase II Study of Brentuximab Vedotin for Patients with Relapsed
                                or Refractory Hodgkin’s Lymphoma'.
                            </p>
                        </div>
                    </div>
                    <div id="slide1aref" style="display: none;" class="slide1aref">
                        <b>References:</b><br />
                        <br />
                        <p>
                            Results of a Pivotal Phase II Study of Brentuximab Vedotin for Patients With Relapsed
                            or Refractory Hodgkin’s Lymphoma. Younes et al. Journal Of Clinical Oncology. June
                            2012.</p>
                    </div>
                </div>
                <div id="slide1" style="display: none;">
                    <!--Body -->
                    <!--<div class="topic-bar">
                        <div id="topic-title">HL: disease description</div>
                     </div>-->
                    <div id="slide1ref" style="display: none;" class="slide1ref">
                        <b>References:</b>
                        <br />
                        1. Pro B, Advani R, Brice P, Bartlett NL, Rosenblatt JD et al. Brentuximab vedotin
                        (SGN-35) in patients with relapsed or refractory systemic anaplastic large-cell
                        lymphoma: results of a phase II study. J Clin Oncol. 2012;30(18):2190-6.
                        <br />
                        2. Pro B, Advani R, Brice P, Bartlett NL, Rosenblatt JD et al. Three-year survival
                        results from an ongoing phase 2 study of brentuximab vedotin in patients with relapsed
                        or refractory systemic anaplastic large cell lymphoma. Poster, Abstract No. 1809,
                        American Society of Hematology, December, 2013, New Orleans, LA, USA.<br />
                        3. ADCETRIS®. Summary of Product Characteristics. 25 October 2012. Available at
                        European Medicines Agency Web site http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/002455/WC500135055.pdf.
                        Accessed on 17 January 2014.<br />
                        4. FDA Approval for Brentuximab Vedotin. National Cancer Institute Web site. Available
                        at: http://www.cancer.gov/cancertopics/druginfo/fda-brentuximabvedotin. Accessed
                        on 17 January 2014.
                    </div>
                    <div class="slidecontent" style="">
                        <div id="popupDiv" class="popupView" style="display: none;">
                            <div style="width: 100%; height: 100%; border-radius: 10px; box-shadow: 1px 1px 7px 0px rgba(0, 0, 0, 0.67);
                                background-color: rgba(255, 255, 255, 0.95); padding-top: 20px;">
                                <div class="fadeInDown" style="display: none; margin-top: 10px;" id="bimg2">
                                    <img src="../common/img/bullet01.png" class="noStyle" style="width: 12px; height: 12px;
                                        float: left; margin: 10px;" />
                                    <p style="padding-left: 40px;">
                                        Salvage chemotherapy and autologous stem-cell transplantation are the standard of
                                        care for relapsed or refractory Hodgkin&#39;s Lymphoma
                                    </p>
                                </div>
                                <div class="fadeInDown" style="display: none" id="bimg3">
                                    <img src="../common/img/bullet01.png" class="noStyle" class="noStyle" style="width: 12px;
                                        height: 12px; float: left; margin: 10px;" />
                                    <p style="padding-left: 40px;">
                                        Auto-SCT can induce long term remissions in approximately 50% of patients.
                                    </p>
                                </div>
                                <button id="btnHide" type="button" class="btn btn-primary" style="display: none;
                                    margin-right: 16px; position: absolute; right: 0; bottom: 0; margin-bottom: 14px;"
                                    onclick="$(this).parent().parent().hide();">
                                    close
                                </button>
                            </div>
                        </div>
                        <div class="playBody">
                            <div style="text-align: center; margin-top: 10px; width: 500px; height: 500px; overflow: hidden;
                                margin: 10px auto;">
                                <img data-class="fadeInDown" id="s1img1" class="border" src="img/Screenshot/Younes-pg1-3.png"
                                    imgwidth="890" imgheight="1234" style="position: relative; margin: 0 auto; display: none" />
                            </div>
                        </div>
                        <div class="playBody">
                            <div style="text-align: center; margin-top: -550px;">
                                <span id='imgZoom'><span class="helper"></span>
                                    <img data-class="fadeInDown" id="s1imag1" class="border" src="img/Screenshot/Younes-pg1-3.png"
                                        style="display: none; position: relative; width: 380px; height: 548px; margin: 0 auto;" />
                                </span>
                            </div>
                        </div>
                    </div>
                    <!--Transcript -->
                    <div onclick="onclickShowTranscription(this);" id="stickyContent" style="display: none;
                        position: absolute; right: 0; margin-top: 184px;">
                        <a href="#">
                            <img src="../common/img/showTrans.png" /></a>
                    </div>
                    <div id="transcript-hide" style="display: none;">
                        <center>
                            <button type="button" class="hidebutton" onclick="onclickHideTranscription(this);">
                                Hide Transcript</button></center>
                        <div class="transcript" style="">
                            <p>
                                The standard of care for patients with relapsed or refractory HL is salvage chemotherapy
                                followed by autologous stem-cell transplantation (auto-SCT) which can induce long
                                term remissions in approximately 50% of patients.
                            </p>
                        </div>
                    </div>
                </div>
                <!--slide 2 starting-->
                <div id="slide2" style="display: none;">
                    <!--Body -->
                    <!--<div class="topic-bar">
                        <div id="topic-title">HL: morphological characteristics</div>
                     </div>-->
                    <div class="slidecontent" style="">
                        <div id="popupDiv1" class="popupView" style="display: none;">
                            <div style="width: 100%; height: 100%; border-radius: 10px; box-shadow: 1px 1px 7px 0px rgba(0, 0, 0, 0.67);
                                background-color: rgba(255, 255, 255, 0.95); padding-top: 20px;">
                                <div class="fadeInDown" style="display: none; margin-top: 10px;" id="bimg3">
                                    <img src="../common/img/bullet01.png" class="noStyle" style="width: 12px; height: 12px;
                                        float: left; margin: 10px;" />
                                    <p style="padding-left: 40px;">
                                        Median survival time about 1.2 years if relapse or progression occurs within 1 year
                                        of auto-SCT
                                    </p>
                                </div>
                                <div class="fadeInDown" style="display: none" id="bimg4">
                                    <img src="../common/img/bullet01.png" class="noStyle" class="noStyle" style="width: 12px;
                                        height: 12px; float: left; margin: 10px;" />
                                    <p style="padding-left: 40px;">
                                        Represents an urgent unmet medical need
                                    </p>
                                </div>
                                <div class="fadeInDown" style="display: none" id="bimg5">
                                    <img src="../common/img/bullet01.png" class="noStyle" class="noStyle" style="width: 12px;
                                        height: 12px; float: left; margin: 10px;" />
                                    <p style="padding-left: 40px;">
                                        A more recent analysis by Arai et al published in 2013 estimated median post-progression
                                        survival for patients who relapse within 12 months after auto-SCT at 0.98 years
                                        (Arai S, et al. Leuk & Lymphoma 2013)
                                    </p>
                                </div>
                                <!-- <button id="Button1" type="button" class="btn btn-primary" style="display: none; margin-right: 16px; position: absolute; right: 0; bottom: 0; margin-bottom: 14px;"
                                    onclick="$(this).parent().parent().hide();">
                                    close
                                </button>-->
                            </div>
                        </div>
                        <div class="playBody">
                            <div style="text-align: center; margin-top: 10px; width: 600px; height: 500px; overflow: hidden;
                                margin: 10px auto;">
                                <img data-class="fadeInDown" id="s2img1" class="border" src="img/Screenshot/Younes-pg1-1.png"
                                    imgwidth="890" imgheight="1234" style="position: relative; margin: 0 auto; display: none" />
                            </div>
                        </div>
                        <div class="playBody">
                            <div style="text-align: center; margin-top: -550px;">
                                <span id='imgZoom1'><span class="helper"></span>
                                    <img data-class="fadeInDown" id="s2imag1" class="border" src="img/Screenshot/Younes-pg1-1.png"
                                        style="display: none; position: relative; width: 380px; height: 548px; margin: 0 auto;" />
                                </span>
                            </div>
                        </div>
                    </div>
                    <!--Transcript -->
                    <div onclick="onclickShowTranscription(this);" id="stickyContent" style="display: none;
                        position: absolute; right: 0; margin-top: 184px;">
                        <a href="#">
                            <img src="../common/img/showTrans.png" /></a>
                    </div>
                    <div id="transcript-hide" style="display: none;">
                        <center>
                            <button type="button" class="hidebutton" onclick="onclickHideTranscription(this);">
                                Hide Transcript</button></center>
                        <div class="transcript" style="">
                            <p>
                                For patients who experience relapse or progressive HL within 1 year after auto-SCT,
                                the prognosis is exceedingly poor, with a median survival time of approximately
                                1.2 years. This population has no currently available standard of care and represents
                                an urgent unmet medical need
                            </p>
                            <p>
                                A more recent analysis by Arai et al published in 2013 estimated median post-progression
                                survival for patients who relapse within 12 months after auto-SCT at 0.98 years.
                            </p>
                        </div>
                    </div>
                    <div id="slide2ref" style="display: none;" class="slide2ref">
                        <b>References:</b><br />
                        <br />
                        Results of a Pivotal Phase II Study of Brentuximab Vedotin for Patients With Relapsed
                        or Refractory Hodgkin’s Lymphoma. Younes et al. Journal Of Clinical Oncology. June
                        2012.
                    </div>
                </div>
                <!--slide 2 ending-->
                <!--slide03 starting-->
                <div id="slide3" style="display: none;">
                    <!--Body -->
                    <!--<div class="topic-bar">
                        <div id="topic-title">HL: CHL</div>
                    </div>-->
                    <div class="slidecontent" style="">
                        <div style="margin: 0 auto; width: 670px;">
                            <div id="popupDiv2" class="popupView" style="display: none;">
                                <div style="width: 100%; height: 107%; border-radius: 10px; box-shadow: 1px 1px 7px 0px rgba(0, 0, 0, 0.67);
                                    background-color: rgba(255, 255, 255, 0.95);">
                                    <div class="fadeInDown" style="display: none; margin: 10px; width: 175px; float: left"
                                        id="s3img2">
                                        <img src="img/HL/figure_1.png" class="noStyle" style="width: 165px; height: 173px;
                                            position: relative; float: left;" />
                                        <p style="font-family: Verdana; font-size: 11px;">
                                            1. The antibody in brentuximab vedotin binds to CD30 on the cell surface and delivers
                                            drug to CD30+ cells
                                        </p>
                                    </div>
                                    <div class="fadeInDown" style="display: none; margin: 10px; width: 175px; float: left"
                                        id="s3img3">
                                        <img src="img/HL/figure_2.png" class="noStyle" class="noStyle" style="width: 165px;
                                            height: 173px; position: relative;" />
                                        <p style="font-family: Verdana; font-size: 11px;">
                                            2. Internalization and lysosomal migration results in enzymatic cleavage of the
                                            ADC to release the cytotoxic agent to the point of action
                                        </p>
                                    </div>
                                    <div class="fadeInDown" style="display: none; margin: 10px; width: 175px; float: left"
                                        id="s3img4">
                                        <img src="img/HL/figure_3.png" class="noStyle" class="noStyle" style="width: 165px;
                                            height: 173px; position: relative;" />
                                        <p style="font-family: Verdana; font-size: 11px;">
                                            3. Microtubular disruption and apoptosis
                                        </p>
                                    </div>
                                    <!-- <button id="Button1" type="button" class="btn btn-primary" style="display: none; margin-right: 16px; position: absolute; right: 0; bottom: 0; margin-bottom: 14px;"
                                    onclick="$(this).parent().parent().hide();">
                                    close
                                </button>-->
                                </div>
                            </div>
                        </div>
                        <div class="playBody">
                            <div style="text-align: center; margin-top: 10px; width: 600px; height: 500px; overflow: hidden;
                                margin: 10px auto;">
                                <img data-class="fadeInDown" id="s3img1" class="border" src="img/Screenshot/Younes-pg1-2.png"
                                    imgwidth="890" imgheight="1234" style="position: relative; margin: 0 auto; display: none" />
                            </div>
                        </div>
                        <div class="playBody">
                            <div style="text-align: center; margin-top: -550px;">
                                <span id='imgZoom2'><span class="helper"></span>
                                    <img data-class="fadeInDown" id="img5" class="border" src="img/Screenshot/Younes-pg1-2.png"
                                        style="display: none; position: relative; width: 380px; height: 548px; margin: 0 auto;" />
                                </span>
                            </div>
                        </div>
                    </div>
                    <!--Transcript -->
                    <div onclick="onclickShowTranscription(this);" id="stickyContent" style="display: none;
                        position: absolute; right: 0; margin-top: 184px;">
                        <a href="#">
                            <img src="../common/img/showTrans.png" /></a>
                    </div>
                    <div id="transcript-hide" style="display: none;">
                        <center>
                            <button type="button" class="hidebutton" onclick="onclickHideTranscription(this);">
                                Hide Transcript</button></center>
                        <div class="transcript" style="">
                            <p>
                                The malignant Hodgkin’s Reed Sternberg cells of classical HL are characterized by
                                the expression of CD30.
                            </p>
                            <p>
                                Brentuximab vedotin (SGN-35) is an antibody drug conjugate (ADC) comprising an anti-CD30
                                antibody conjugated by a protease cleavable linker to the potent antimicrotubule
                                agent, monomethyl auristatin E (MMAE). The novel linker used in brentuximab vedotin
                                is highly stable, ensuring that MMAE is released after lysosome entry.
                            </p>
                            <p>
                                After internalisation and migration to the lysosome, enzymatic cleavage of the ADC
                                occurs to release the cytotoxic agent to the point of action. MMAE is released into
                                the CD30+ cells and results in programmed cell death or apoptosis due to microtubule
                                disruption.
                            </p>
                        </div>
                    </div>
                    <div id="slide3ref" style="display: none;" class="slide3ref">
                        <b>References:</b><br />
                        <br />
                        Results of a Pivotal Phase II Study of Brentuximab Vedotin for Patients With Relapsed
                        or Refractory Hodgkin’s Lymphoma. Younes et al. Journal Of Clinical Oncology. June
                        2012.
                    </div>
                </div>
                <!--slide03 ending-->
                <!--slide 4 starting-->
                <div id="slide4" style="display: none;">
                    <!--<div class="topic-bar">
                        <div id="topic-title">HL: epidemiology</div>
                    </div>-->
                    <!--Body -->
                    <div class="slidecontent" style="">
                        <div id="popupDiv3" class="popupView" style="display: none;">
                            <div style="width: 100%; height: 100%; border-radius: 10px; box-shadow: 1px 1px 7px 0px rgba(0, 0, 0, 0.67);
                                background-color: rgba(255, 255, 255, 0.95); padding-top: 20px;">
                                <div class="fadeInDown" style="display: none; margin-top: 10px;" id="txt1">
                                    <p style="padding-left: 10px;">
                                        Patients with
                                    </p>
                                </div>
                                <div class="fadeInDown" style="display: none; margin-top: 10px;" id="bimg3">
                                    <img src="../common/img/bullet01.png" class="noStyle" style="width: 12px; height: 12px;
                                        float: left; margin: 10px;" />
                                    <p style="padding-left: 40px;">
                                        Relapsed or refractory HL after high-dose chemotherapy and auto-SCT
                                    </p>
                                </div>
                                <div class="fadeInDown" style="display: none; margin-top: 10px;" id="bimg4">
                                    <img src="../common/img/bullet01.png" class="noStyle" style="width: 12px; height: 12px;
                                        float: left; margin: 10px;" />
                                    <p style="padding-left: 40px;">
                                        Histologically documented CD30-positive Hodgkin’s Reed-Sternberg cells
                                    </p>
                                    </p>
                                </div>
                                <!-- <button id="Button1" type="button" class="btn btn-primary" style="display: none; margin-right: 16px; position: absolute; right: 0; bottom: 0; margin-bottom: 14px;"
                                    onclick="$(this).parent().parent().hide();">
                                    close
                                </button>-->
                            </div>
                        </div>
                        <div class="playBody">
                            <div style="text-align: center; margin-top: 10px; width: 500px; height: 500px; overflow: hidden;
                                margin: 10px auto;">
                                <img data-class="fadeInDown" id="s4img1" class="border" src="img/Screenshot/Younes-pg2-1.png"
                                    imgwidth="890" imgheight="1234" style="position: relative; margin: 0 auto; display: none" />
                            </div>
                        </div>
                        <div class="playBody">
                            <div style="text-align: center; margin-top: -550px;">
                                <span id='imgZoom3'><span class="helper"></span>
                                    <img data-class="fadeInDown" id="s4imag1" class="border" src="img/Screenshot/Younes-pg2-1.png"
                                        style="display: none; position: relative; width: 380px; height: 548px; margin: 0 auto;" />
                                </span>
                            </div>
                        </div>
                    </div>
                    <!--Transcript-->
                    <div onclick="onclickShowTranscription(this);" id="stickyContent" style="display: none;
                        position: absolute; right: 0; margin-top: 184px;">
                        <a href="#">
                            <img src="../common/img/showTrans.png" /></a>
                    </div>
                    <div id="transcript-hide" style="display: none;">
                        <center>
                            <button type="button" class="hidebutton" onclick="onclickHideTranscription(this);">
                                Hide Transcript</button></center>
                        <div class="transcript" style="">
                            <p>
                                This phase II trial included subjects with relapsed or refractory HL after high-dose
                                chemotherapy and auto-SCT, histologically documented CD30-positive Hodgkin’s Reed-Sternberg
                                cells by central pathology review, and age 12 years or older.
                            </p>
                        </div>
                    </div>
                    <div id="slide4ref" style="display: none" class="slide4ref">
                        <b>References:</b><br />
                        <br />
                        <p>
                            Results of a Pivotal Phase II Study of Brentuximab Vedotin for Patients With Relapsed
                            or Refractory Hodgkin’s Lymphoma. Younes et al. Journal Of Clinical Oncology. June
                            2012.
                        </p>
                    </div>
                </div>
                <!--slide 4 ending-->
                <!--slide 5 starting-->
                <div id="slide5" style="display: none;">
                    <!--<div class="topic-bar">
                        <div id="topic-title">Knowledge Check</div>
                    </div>
                 <!--Body -->
                    <div class="slidecontent" style="">
                        <div id="popupDiv4" class="popupView" style="display: none;">
                            <div style="width: 100%; height: 100%; border-radius: 10px; box-shadow: 1px 1px 7px 0px rgba(0, 0, 0, 0.67);
                                background-color: rgba(255, 255, 255, 0.95); padding-top: 20px;">
                                <div class="fadeInDown" style="display: none; margin-top: 10px;" id="s5bimg1">
                                    <img src="../common/img/bullet01.png" class="noStyle" style="width: 12px; height: 12px;
                                        float: left; margin: 10px;" />
                                    <p style="padding-left: 40px;">
                                        Up to 16 cycles of 1.8 mg/kg IV once every 3 weeks
                                    </p>
                                </div>
                                <div class="fadeInDown" style="display: none; margin-top: 10px;" id="s5bimg2">
                                    <img src="../common/img/bullet01.png" class="noStyle" style="width: 12px; height: 12px;
                                        float: left; margin: 10px;" />
                                    <p style="padding-left: 40px;">
                                        Investigators and an independent reviewer assessed clinical response and imaging
                                    </p>
                                    </p>
                                </div>
                            </div>
                        </div>
                        <div class="playBody">
                            <div style="text-align: center; margin-top: 10px; width: 500px; height: 500px; overflow: hidden;
                                margin: 10px auto;">
                                <img data-class="fadeInDown" id="s5img1" class="border" src="img/Screenshot/Younes-pg2-6.png"
                                    imgwidth="890" imgheight="1234" style="position: relative; margin: 0 auto; display: none" />
                            </div>
                        </div>
                        <div class="playBody">
                            <div style="text-align: center; margin-top: -550px;">
                                <span id='imgZoom4'><span class="helper"></span>
                                    <img data-class="fadeInDown" id="s5imag1" class="border" src="img/Screenshot/Younes-pg2-6.png"
                                        style="display: none; position: relative; width: 380px; height: 548px; margin: 0 auto;" />
                                </span>
                            </div>
                        </div>
                    </div>
                    <!--Transcript -->
                    <div onclick="onclickShowTranscription(this);" id="stickyContent" style="display: none;
                        position: absolute; right: 0; margin-top: 184px;">
                        <a href="#">
                            <img src="../common/img/showTrans.png" /></a>
                    </div>
                    <div id="transcript-hide" style="display: none;">
                        <center>
                            <button type="button" class="hidebutton" onclick="onclickHideTranscription(this);">
                                Hide Transcript</button></center>
                        <div class="transcript" style="">
                            <p>
                                1.8 mg/kg of brentuximab vedotin was administered intravenously once every 3 weeks
                                over 30 minutes on an outpatient basis for up to 16 infusions.
                            </p>
                            <p>
                                Study assessments such as bone marrow biopsy, CT and PET scan were conducted and
                                the best clinical response was determined according to the Revised Response Criteria
                                for Malignant Lymphoma by both investigators and an independent reviewer.
                            </p>
                        </div>
                    </div>
                    <div id="slide5ref" style="display: none" class="slide5ref">
                        <b>References:</b><br />
                        <br />
                        <p>
                            Results of a Pivotal Phase II Study of Brentuximab Vedotin for Patients With Relapsed
                            or Refractory Hodgkin’s Lymphoma. Younes et al. Journal Of Clinical Oncology. June
                            2012.
                        </p>
                    </div>
                </div>
                <!--slide 5 ending-->
                <!--slide 6 starting-->
                <div id="slide6" style="display: none;">
                    <!-- <div class="topic-bar">
                        <div id="topic-title">HL: survival rates</div>
                    </div>-->
                    <!--Body -->
                    <div class="slidecontent" style="">
                        <div id="popupDiv4" class="popupView" style="display: none;">
                            <div style="width: 100%; height: 100%; border-radius: 10px; box-shadow: 1px 1px 7px 0px rgba(0, 0, 0, 0.67);
                                background-color: rgba(255, 255, 255, 0.95); padding-top: 20px;">
                                <div class="fadeInDown" style="display: none; margin-top: 10px;" id="s5bimg1">
                                    <img src="../common/img/bullet01.png" class="noStyle" style="width: 12px; height: 12px;
                                        float: left; margin: 10px;" />
                                    <p style="padding-left: 40px;">
                                        Up to 16 cycles of 1.8 mg/kg IV once every 3 weeks
                                    </p>
                                </div>
                                <div class="fadeInDown" style="display: none; margin-top: 10px;" id="s5bimg2">
                                    <img src="../common/img/bullet01.png" class="noStyle" style="width: 12px; height: 12px;
                                        float: left; margin: 10px;" />
                                    <p style="padding-left: 40px;">
                                        Investigators and an independent reviewer assessed clinical response and imaging
                                    </p>
                                </div>
                            </div>
                        </div>
                        <div class="playBody">
                            <div style="text-align: center; margin-top: 10px; width: 500px; height: 500px; overflow: hidden;
                                margin: 10px auto;">
                                <img data-class="fadeInDown" id="s6img1" class="border" src="img/Screenshot/Younes-pg2-4.png"
                                    imgwidth="890" imgheight="1234" style="position: relative; margin: 0 auto; display: none" />
                            </div>
                        </div>
                        <div class="playBody">
                            <div style="text-align: center; margin-top: 10px; width: 500px; height: 500px; overflow: hidden;
                                margin: -540px auto;">
                                <img data-class="fadeInDown" id="s6img2" class="border" src="img/Screenshot/Younes-pg3-1.png"
                                    imgwidth="890" imgheight="1234" style="position: relative; margin: 0 auto; display: none" />
                            </div>
                        </div>
                        <div id="s6table1" style="position: absolute; width: 685px; display: none;">
                            <table style="width: 98%;" class="imagTab" cellpadding="10px">
                                <tr>
                                    <td style="width: 50%;">
                                        <img data-class="fadeInDown" onclick="callImageZoom(this)" src="img/Screenshot/Younes-pg2-4.png"
                                            id="s6imag1" style="width: 100%" />
                                    </td>
                                    <!--<td> <span id='imgZoom5'><img data-class="fadeInDown" class="border" src="img/screenshot/Younes-img-2.png" id="s6img2" style="height: 115px;"/></span></td>-->
                                    <td style="width: 50%;">
                                        <img onclick="callImageZoom(this)" data-class="fadeInDown" src="img/Screenshot/Younes-pg3-1.png"
                                            id="s6imag2" style="width: 100%" /></td>
                                </tr>
                            </table>
                        </div>
                        <div class="zoomedDiv" style="text-align: center; position: relative; display: none;">
                            <span id='imgZoom'><span class="helper"></span>
                                <img id="zoomShowImg" style="height: 545px; padding: 10px; margin: 0 auto;" />
                                <button type="button" onclick="$(this).parent().parent().hide();" class="btn btn-primary"
                                    style="position: absolute; margin-top: -50px; z-index: 100; right: 0; margin-right: 20px;">
                                    Close</button>
                            </span>
                        </div>
                    </div>
                    <!--Transcript -->
                    <div onclick="onclickShowTranscription(this);" id="stickyContent" style="display: none;
                        position: absolute; right: 0; margin-top: 184px;">
                        <a href="#">
                            <img src="../common/img/showTrans.png" /></a>
                    </div>
                    <div id="transcript-hide" style="display: none;">
                        <center>
                            <button type="button" class="hidebutton" onclick="onclickHideTranscription(this);">
                                Hide Transcript</button></center>
                        <div class="transcript">
                            <p>
                                Seventy-one percent of the patients had primary refractory disease, and 42% had
                                disease that was refractory to the most recent prior therapy.
                            </p>
                            <p>
                                The median number of prior chemotherapy regimens excluding auto-SCT was 3.5.
                            </p>
                            <p>
                                Sixty-six percent of patients had received prior radiation therapy, and all 102
                                patients had undergone auto-SCT of which a majority of patients (71%) had experienced
                                relapse within a year of auto-SCT. The median time to relapse after auto-SCT was
                                6.7 months.
                            </p>
                        </div>
                    </div>
                    <div id="slide6ref" style="display: none;" class="slide6ref">
                        <b>References:</b><br />
                        <br />
                        Results of a Pivotal Phase II Study of Brentuximab Vedotin for Patients With Relapsed
                        or Refractory Hodgkin’s Lymphoma. Younes et al. Journal Of Clinical Oncology. June
                        2012.
                    </div>
                </div>
                <!--slide 6 ending-->
                <div id="slide6a" style="display: none;">
                    <!-- <div class="topic-bar">
                        <div id="topic-title">HL: survival rates</div>
                    </div>-->
                    <!--Body -->
                    <div class="slidecontent" style="">
                        <div class="playBody">
                            <div style="padding-left: 20px">
                                <br />
                                <p data-class="fadeInDown" style="display: none;" id="s6atxt1">
                                    Identify the False statement?
                                </p>
                                <br />
                                <input type="hidden" id="Answer" value="5" qid="1" />
                                <input type="hidden" id="Percentage" value="25" />
                                <div id="radio1" style="padding: 10px 25px 10px 10px; display: none;">
                                    <input name="ratio1" value="1" type="radio" style="width: 2em; height: 1.5em; float: left;" />
                                    <p data-class="fadeInRight" style="padding-left: 55px;">
                                        Seventy-one percent of the patients had primary refractory disease</p>
                                </div>
                                <div id="radio2" style="padding: 10px 25px 10px 10px; display: none;">
                                    <input name="ratio1" value="2" type="radio" style="width: 2em; height: 1.5em; float: left;" />
                                    <p data-class="fadeInRight" style="padding-left: 55px;">
                                        42% had disease that was refractory to the most recent prior therapy</p>
                                </div>
                                <div id="radio3" style="padding: 10px 25px 10px 10px; display: none;">
                                    <input name="ratio1" value="3" type="radio" style="width: 2em; height: 1.5em; float: left;" />
                                    <p data-class="fadeInRight" style="padding-left: 55px;">
                                        The median number of prior chemotherapy regimens excluding auto-SCT was 3.5</p>
                                </div>
                                <div id="radio4" style="padding: 10px 25px 10px 10px; display: none;">
                                    <input name="ratio1" value="4" type="radio" style="width: 2em; height: 1.5em; float: left;" />
                                    <p data-class="fadeInRight" style="padding-left: 55px;">
                                        All 102 patients had undergone auto-SCT of which a majority of patients (71%) had
                                        experienced relapse within a year of auto-SCT</p>
                                </div>
                                <div id="radio5" style="padding: 10px 25px 10px 10px; display: none;">
                                    <input name="ratio1" value="5" type="radio" style="width: 2em; height: 1.5em; float: left;" />
                                    <p data-class="fadeInRight" style="padding-left: 55px;">
                                        None of the above</p>
                                </div>
                                <div style="margin-left: 470px;">
                                    <div>
                                        <input id="s6aimag9" onclick="onclickAnswer(this);" type="button" class="btn btn-primary"
                                            value="Submit" style="width: 100px; margin-right: 25px; display: none" />
                                    </div>
                                    <br />
                                </div>
                            </div>
                        </div>
                    </div>
                    <!--Transcript -->
                    <div onclick="onclickShowTranscription(this);" id="stickyContent" style="display: none;
                        position: absolute; right: 0; margin-top: 184px;">
                        <a href="#">
                            <img src="../common/img/showTrans.png" /></a>
                    </div>
                    <div id="transcript-hide" style="display: none;">
                        <center>
                            <button type="button" class="hidebutton" onclick="onclickHideTranscription(this);">
                                Hide Transcript</button></center>
                        <div class="transcript">
                            Please take a moment to answer a question. Please select the best answer and click
                            submit to continue.
                        </div>
                    </div>
                    <div id="slide6aref" style="display: none;" class="slide6aref">
                        <b>References:</b><br />
                        <br />
                        Results of a Pivotal Phase II Study of Brentuximab Vedotin for Patients With Relapsed
                        or Refractory Hodgkin’s Lymphoma. Younes et al. Journal Of Clinical Oncology. June
                        2012.
                    </div>
                </div>
                <!--slide 6a ending-->
                <!--slide 7 starting-->
                <div id="slide7" style="display: none;">
                    <!--<div class="topic-bar">
                        <div id="topic-title">HL: predisposing factors</div>
                    </div>-->
                    <div class="slidecontent" style="">
                        <div class="playBody">
                            <div style="text-align: center; margin-top: 10px; width: 400px; height: 500px; overflow: hidden;
                                margin: 10px auto;">
                                <img data-class="fadeInDown" id="s7img22" class="border" src="img/Screenshot/Younes-pg4-1.png"
                                    imgwidth="890" imgheight="1234" style="position: relative; margin: 0 auto; display: none" />
                            </div>
                        </div>
                        <div class="playBody">
                            <div style="text-align: center; margin-top: -550px;">
                                <span id='imgZoom7'><span class="helper"></span>
                                    <img data-class="fadeInDown" id="img7" class="border" src="img/Screenshot/Younes-pg4-1.png"
                                        style="display: none; position: relative; width: 380px; height: 548px; margin: 0 auto;" />
                                </span>
                            </div>
                        </div>
                    </div>
                    <!--Transcript -->
                    <div onclick="onclickShowTranscription(this);" id="stickyContent" style="display: none;
                        position: absolute; right: 0; margin-top: 184px;">
                        <a href="#">
                            <img src="../common/img/showTrans.png" /></a>
                    </div>
                    <div id="transcript-hide" style="display: none;">
                        <center>
                            <button type="button" class="hidebutton" onclick="onclickHideTranscription(this);">
                                Hide Transcript</button></center>
                        <div class="transcript">
                            <p>
                                The objective response rate (ORR) was 75%. 34% of all patients achieved a complete
                                response.
                            </p>
                            <p>
                                Tumour reductions were observed in 94% of patients.
                            </p>
                            <p>
                                96% achieved overall disease control which is a measure of complete remission (CR),
                                partial remission and stable disease together.
                            </p>
                        </div>
                    </div>
                    <div id="slide7ref" style="display: none;" class="slide7ref">
                        <b>References:</b><br />
                        <br />
                        Results of a Pivotal Phase II Study of Brentuximab Vedotin for Patients With Relapsed
                        or Refractory Hodgkin’s Lymphoma. Younes et al. Journal Of Clinical Oncology. June
                        2012.
                    </div>
                </div>
                <!--slide 7 ending-->
                <!--slide 8 starting-->
                <div id="slide8" style="display: none;">
                    <!--<div class="topic-bar">
                        <div id="topic-title">HL: clinical presentation (1)</div>
                    </div>-->
                    <div class="slidecontent" style="">
                        <!--<div class="playBody">
                            <div style="text-align: center; margin-top: 10px;">
                                <img data-class="fadeInDown" id="s8img1" class="border" src="img/screenshot/Younes-img-3.png"
                                    style="display: none; width:380px;" />
                            </div>
                            <div style="text-align: center; margin-top: 10px;">
                                <img data-class="fadeInDown" id="s8img2" class="border" src="img/screenshot/screenshot_11.png"
                                    style="display: none;" />
                            </div>
                       
                        <div>
                            <div class="fadeInDown" style="display: none; margin-top: 20px;" id="s8bimg4">
                                <img src="../common/img/bullet01.png" class="noStyle" style="width: 12px; height: 12px;
                                    float: left; margin: 10px;" />
                                <p>
                                    Median duration of response in patients with objective response was 6.7 months.
                                </p>
                            </div>
                            <div class="fadeInDown" style="display: none" id="s8bimg5">
                                <img src="../common/img/bullet01.png" class="noStyle" style="width: 12px; height: 12px;
                                    float: left; margin: 10px;" />
                                <p>
                                    Median duration of response in patients with complete response was 20.5 months
                                </p>
                            </div>
                            <div class="fadeInDown" style="display: none; margin-top: -30px; margin-left: 10px;"
                                id="s8bimg6">
                                <img src="../common/img/bullet01.png" class="noStyle" style="width: 12px; height: 12px;
                                    float: left; margin: 10px;" />
                                <p>
                                    The estimated 12-month survival was 89%
                                </p>
                            </div>
                            <div class="fadeInDown" style="display: none; margin-left: 10px;" id="s8bimg7">
                                <img src="../common/img/bullet01.png" class="noStyle" style="width: 12px; height: 12px;
                                    float: left; margin: 10px;" />
                                <p>
                                    Median PFS in patients with complete response was 21.7 months
                                </p>
                            </div>
                        </div>
                        </div>-->
                        <div class="playBody">
                            <div style="text-align: center; margin-top: 10px; width: 400px; height: 500px; overflow: hidden;
                                margin: 10px auto;">
                                <img data-class="fadeInDown" id="s8img2" class="border" src="img/Screenshot/Younes-s13.png"
                                    imgwidth="890" imgheight="1234" style="position: relative; margin: 0 auto; display: none" />
                            </div>
                        </div>
                        <div class="playBody">
                            <div style="text-align: center; margin-top: -550px;">
                                <span id='imgZoom8'><span class="helper"></span>
                                    <img data-class="fadeInDown" id="img8" class="border" src="img/Screenshot/Younes-s13.png"
                                        style="display: none; position: relative; width: 380px; height: 548px; margin: 0 auto;" />
                                </span>
                            </div>
                        </div>
                    </div>
                    <!--Transcript -->
                    <div onclick="onclickShowTranscription(this);" id="stickyContent" style="display: none;
                        position: absolute; right: 0; margin-top: 184px;">
                        <a href="#">
                            <img src="../common/img/showTrans.png" /></a>
                    </div>
                    <div id="transcript-hide" style="display: none;">
                        <center>
                            <button type="button" class="hidebutton" onclick="onclickHideTranscription(this);">
                                Hide Transcript</button></center>
                        <div class="transcript">
                            <br />
                            <p>
                                The median duration of response was 6.7 months in patients who had an objective
                                response. The median duration of response for patients who achieved a CR was 20.5
                                months
                            </p>
                            <p>
                                The estimated 12-month survival was 89%.
                            </p>
                            <p>
                                The median progression free survival (PFS) for patients who achieved a CR with brentuximab
                                vedotin was 21.7 months, which was notably longer than the median PFS for patients
                                who did not obtain a complete response
                            </p>
                        </div>
                    </div>
                    <div id="slide8ref" style="display: none" class="slide8ref">
                        <b>References:</b><br />
                        <br />
                        Results of a Pivotal Phase II Study of Brentuximab Vedotin for Patients With Relapsed
                        or Refractory Hodgkin’s Lymphoma. Younes et al. Journal Of Clinical Oncology. June
                        2012.
                    </div>
                </div>
                <!--slide 8 ending-->
                <!--slide 9 starting-->
                <div id="slide9" style="display: none;">
                    <!--<div class="topic-bar">
                        <div id="topic-title">HL: clinical presentation (2)</div>
                    </div>-->
                    <div class="slidecontent" style="">
                        <!--<div data-class="fadeInDown" style="display: none; margin-top: 10px;" id="s9bimg4">
                        <img src="../common/img/bullet01.png" class="noStyle" style="width: 12px; height: 12px;
                            float: left; margin: 10px;" />
                        <p>
                            Median PFS with prior therapy was 4.1 months
                        </p>
                    </div>
                    <div style="text-align: center;">
                        <img data-class="fadeInDown" id="s9img3" src="img/2.png" class="noStyle" style="display: none;
                            margin-top: 20px;" />
                    </div>
                    <div data-class="fadeInDown" style="display: none; margin-top: 10px;" id="s9bimg5">
                        <img src="../common/img/bullet01.png" class="noStyle" style="width: 12px; height: 12px;
                            float: left; margin-top: 7px; margin-left: 27px;" />
                        <p style="padding-left: 60px;">
                            Median PFS with brentuximab vedotin was 7.8 months
                        </p>
                    </div>-->
                        <div class="playBody">
                            <div style="text-align: center; margin-top: 10px; width: 500px; height: 500px; overflow: hidden;
                                margin: 10px auto;">
                                <img data-class="fadeInDown" id="s9img1" class="border" src="img/Screenshot/frame12.png"
                                    imgwidth="890" imgheight="1234" style="position: relative; margin: 0 auto; display: none" />
                            </div>
                        </div>
                        <div class="playBody">
                            <div style="text-align: center; margin-top: 10px; width: 500px; height: 500px; overflow: hidden;
                                margin: -540px auto;">
                                <img data-class="fadeInDown" id="s9img2" class="border" src="img/Screenshot/Younes-pg5-1.png"
                                    imgwidth="890" imgheight="1234" style="position: relative; margin: 0 auto; display: none" />
                            </div>
                        </div>
                        <div style="margin: 0 auto; width:670px;">
                        <div id="s9table1" style="position: absolute; width: 685px; display: none;">
                            <table style="width: 98%;" class="imagTab" cellpadding="10px">
                                <tr>
                                    <td style="width: 50%;">
                                        <img data-class="fadeInDown" onclick="callImageZoom(this)" src="img/Screenshot/frame12.png"
                                            id="s9img1" style="width: 100%" />
                                    </td>
                                    <td style="width: 50%;">
                                        <img onclick="callImageZoom(this)" data-class="fadeInDown" src="img/Screenshot/Younes-pg5-1.png"
                                            id="s9img2" style="width: 100%" />
                                    </td>
                                </tr>
                            </table>
                        </div>
                        </div>
                        <div class="zoomedDiv" style="text-align: center; position: relative; display: none;">
                            <span id='imgZoom'><span class="helper"></span>
                                <img id="zoomShowImg" style="height: 545px; padding: 10px; margin: 0 auto;" />
                                <button type="button" onclick="$(this).parent().parent().hide();" class="btn btn-primary"
                                    style="position: absolute; margin-top: -50px; z-index: 100; right: 0; margin-right: 20px;">
                                    Close</button>
                            </span>
                        </div>
                    </div>
                    <!--Transcript -->
                    <div onclick="onclickShowTranscription(this);" id="stickyContent" style="display: none;
                        position: absolute; right: 0; margin-top: 184px;">
                        <a href="#">
                            <img src="../common/img/showTrans.png" /></a>
                    </div>
                    <div id="transcript-hide" style="display: none;">
                        <center>
                            <button type="button" class="hidebutton" onclick="onclickHideTranscription(this);">
                                Hide Transcript</button></center>
                        <div class="transcript">
                            <p>
                                A subset of patients (57 of 102 patients) had received a systemic therapy at the
                                time of relapse after auto-SCT. The PFS achieved with the most recent prior systemic
                                therapy and that achieved with brentuximab vedotin was analysed.
                            </p>
                            <p>
                                The median PFS achieved with the most recent prior systemic therapy was 4.1 months
                                and when these same patients subsequently received brentuximab vedotin, the median
                                PFS was 7.8 months indicating a significant increase with brentuximab vedotin treatment.
                            </p>
                        </div>
                    </div>
                    <div id="slide9ref" style="display: none" class="slide9ref">
                        <b>References:</b><br />
                        <br />
                        Results of a Pivotal Phase II Study of Brentuximab Vedotin for Patients With Relapsed
                        or Refractory Hodgkin’s Lymphoma. Younes et al. Journal Of Clinical Oncology. June
                        2012.
                    </div>
                </div>
                <!--slide 9 ending-->
                <div id="slide9a" style="display: none;">
                    <!-- <div class="topic-bar">
                        <div id="topic-title">HL: survival rates</div>
                    </div>-->
                    <!--Body -->
                    <div class="slidecontent" style="">
                        <div class="playBody">
                            <div style="padding-left: 20px">
                                <br />
                                <p data-class="fadeInDown" style="display: none;" id="s9atxt1">
                                    Median PFS in patients who received brentuximab vedotin compared to the median PFS
                                    achieved with the most recent prior systemic therapy was
                                </p>
                                <br />
                                <input type="hidden" id="Answer" value="1" qid="2"/>
                                <input type="hidden" id="Percentage" value="25" />
                                <div id="radio1" style="padding: 10px 25px 10px 10px; display: none;">
                                    <input name="ratio2" value="1" type="radio" style="width: 2em; height: 1.5em; float: left;" />
                                    <p data-class="fadeInRight" style="padding-left: 55px;">
                                        Significantly increased</p>
                                </div>
                                <div id="radio2" style="padding: 10px 25px 10px 10px; display: none;">
                                    <input name="ratio2" value="2" type="radio" style="width: 2em; height: 1.5em; float: left;" />
                                    <p data-class="fadeInRight" style="padding-left: 55px;">
                                        Significantly decreased</p>
                                </div>
                                <div id="radio3" style="padding: 10px 25px 10px 10px; display: none;">
                                    <input name="ratio2" value="3" type="radio" style="width: 2em; height: 1.5em; float: left;" />
                                    <p data-class="fadeInRight" style="padding-left: 55px;">
                                        Not changed</p>
                                </div>
                                <div id="radio4" style="padding: 10px 25px 10px 10px; display: none;">
                                    <input name="ratio2" value="4" type="radio" style="width: 2em; height: 1.5em; float: left;" />
                                    <p data-class="fadeInRight" style="padding-left: 55px;">
                                        Lesser but insignificant</p>
                                </div>
                                <div style="margin-left: 470px;">
                                    <div>
                                        <input id="s9aimag9" onclick="onclickAnswer(this);" type="button" class="btn btn-primary"
                                            value="Submit" style="width: 100px; margin-right: 25px; display: none" />
                                    </div>
                                    <br />
                                </div>
                            </div>
                        </div>
                    </div>
                    <!--Transcript -->
                    <div onclick="onclickShowTranscription(this);" id="stickyContent" style="display: none;
                        position: absolute; right: 0; margin-top: 184px;">
                        <a href="#">
                            <img src="../common/img/showTrans.png" /></a>
                    </div>
                    <div id="transcript-hide" style="display: none;">
                        <center>
                            <button type="button" class="hidebutton" onclick="onclickHideTranscription(this);">
                                Hide Transcript</button></center>
                        <div class="transcript">
                            <br />
                            Please take a moment to answer a question. Please select the best answer and click
                            submit to continue.
                        </div>
                    </div>
                    <div id="slide9aref" style="display: none;" class="slide6ref">
                        <b>References:</b><br />
                        <br />
                        Results of a Pivotal Phase II Study of Brentuximab Vedotin for Patients With Relapsed
                        or Refractory Hodgkin’s Lymphoma. Younes et al. Journal Of Clinical Oncology. June
                        2012.
                    </div>
                </div>
                <!--slide 9a ending-->
                <!--slide 10 starting-->
                <div id="slide10" style="display: none;">
                    <!--<div class="topic-bar">
                        <div id="topic-title">HL: clinical presentation (2)</div>
                    </div>-->
                    <div class="slidecontent" style="">
                        <!--<div class="playBody">
                            <div style="">
                                <div style="text-align: center; margin-top: 10px;">
                                    <img data-class="fadeInDown" id="s10img1" class="border" src="img/screenshot/Younes-img-3.png"
                                        style="display: none; width: 380px;" />
                                </div>
                                <div style="text-align: center; margin-top: 10px;">
                                    <img data-class="fadeInDown" id="s10img2" class="border" src="img/screenshot/Younes-img-5.png"
                                        style="display: none; width: 380px;" />
                                </div>
                                <div style="text-align: center; margin-top: 10px;">
                                    <img data-class="fadeInDown" id="s10img3" class="border" src="img/screenshot/Younes-img-4.png"
                                        style="display: none; width: 380px;" />
                                </div>
                                <div style="text-align: center; margin-top: 10px;">
                                    <img data-class="fadeInDown" id="s10img4" class="border" src="img/screenshot/Younes-img-5.png"
                                        style="display: none; width: 380px;" />
                                </div>
                                <div style="height: 50%; width: 99%;">
                                    <div id="s10hdn4">
                                        <div data-class="fadeInDown" style="display: none; padding-left: 20px;" id="s10bimg1">
                                            <img src="../common/img/bullet01.png" class="noStyle" style="width: 12px; height: 12px;
                                                float: left; margin: 10px;" />
                                            <p style="">
                                                The median number of cycles was 9
                                            </p>
                                        </div>
                                        <div data-class="fadeInDown" style="display: none; width: 101%; padding-left: 20px;"
                                            id="s10bimg2">
                                            <img src="../common/img/bullet01.png" class="noStyle" style="width: 12px; height: 12px;
                                                float: left; margin: 10px;" />
                                            <p>
                                                55% of the patients experienced adverse events of grade 3 or higher severity
                                            </p>
                                        </div>
                                        <div data-class="fadeInDown" style="display: none; padding-left: 20px;" id="s10bimg3">
                                            <img src="../common/img/bullet01.png" class="noStyle" style="width: 12px; height: 12px;
                                                float: left; margin: 10px;" />
                                            <p style="">
                                                20 patients had adverse events that led to discontinuation of treatment
                                            </p>
                                        </div>
                                        <div data-class="fadeInDown" style="display: none; padding-left: 20px;" id="s10bimg4">
                                            <img src="../common/img/bullet01.png" class="noStyle" style="width: 12px; height: 12px;
                                                float: left; margin: 10px;" />
                                            <p style="">
                                                47% patients had delayed doses of brentuximab vedotin due to adverse events
                                            </p>
                                        </div>
                                    </div>
                                    <div data-class="fadeInDown" style="display: none; padding-left: 20px;" id="s10bimg5">
                                        <img src="../common/img/bullet01.png" class="noStyle" style="width: 12px; height: 12px;
                                            float: left; margin: 10px;" />
                                        <p>
                                            The median time to onset of peripheral neuropathy events was 12.4 weeks
                                        </p>
                                    </div>
                                    <div data-class="fadeInDown" style="display: none; padding-left: 20px;" id="s10bimg6">
                                        <img src="../common/img/bullet01.png" class="noStyle" style="width: 12px; height: 12px;
                                            float: left; margin: 10px;" />
                                        <p style="">
                                            There were no grade 4 peripheral neuropathy events.
                                        </p>
                                    </div>
                                    <div data-class="fadeInDown" style="display: none; padding-left: 20px;" id="s10bimg7">
                                        <img src="../common/img/bullet01.png" class="noStyle" style="width: 12px; height: 12px;
                                            float: left; margin: 10px;" />
                                        <p style="">
                                            Resolution or at least 1 grade improvement of peripheral neuropathy in 80% of patients
                                        </p>
                                    </div>
                                    <div data-class="fadeInDown" style="display: none; padding-left: 20px;" id="s10bimg8">
                                        <img src="../common/img/bullet01.png" class="noStyle" style="width: 12px; height: 12px;
                                            float: left; margin: 10px;" />
                                        <p style="">
                                            Complete resolution of peripheral neuropathy in 50% of patients
                                        </p>
                                    </div>
                                    <div data-class="fadeInDown" style="display: none; padding-left: 20px;" id="s10bimg9">
                                        <img src="../common/img/bullet01.png" class="noStyle" style="width: 12px; height: 12px;
                                            float: left; margin: 10px;" />
                                        <p style="">
                                            Median time to improvement or resolution of peripheral neuropathy was 13.2 weeks
                                        </p>
                                    </div>
                                </div>
                            </div>
                        </div>-->
                        <div class="playBody">
                            <div style="text-align: center; margin-top: 10px; width: 500px; height: 500px; overflow: hidden;
                                margin: 10px auto;">
                                <img data-class="fadeInDown" id="s10img1" class="border" src="img/Screenshot/saftya.png"
                                    imgwidth="890" imgheight="1234" style="position: relative; margin: 0 auto; display: none" />
                            </div>
                        </div>
                        <div class="playBody">
                            <div style="text-align: center; margin-top: 10px; width: 500px; height: 500px; overflow: hidden;
                                margin: -540px auto;">
                                <img data-class="fadeInDown" id="s10img2" class="border" src="img/Screenshot/Younes-pg4-2.png"
                                    imgwidth="890" imgheight="1234" style="position: relative; margin: 0 auto; display: none" />
                            </div>
                        </div>
                        <div class="playBody">
                            <div style="text-align: center; margin-top: 10px; width: 500px; height: 500px; overflow: hidden;
                                margin: -540px auto;">
                                <img data-class="fadeInDown" id="s10img3" class="border" src="img/Screenshot/saftyb.png"
                                    imgwidth="890" imgheight="1234" style="position: relative; margin: 0 auto; display: none" />
                            </div>
                        </div>
                        <div class="playBody">
                            <div style="text-align: center; margin-top: 10px; width: 500px; height: 500px; overflow: hidden;
                                margin: -540px auto;">
                                <img data-class="fadeInDown" id="s10img4" class="border" src="img/Screenshot/Younes-pg4-2.png"
                                    imgwidth="890" imgheight="1234" style="position: relative; margin: 0 auto; display: none" />
                            </div>
                        </div>
                        <!--<div class="playBody">
                            <div style="text-align: center; margin-top: 10px; width: 500px; height: 500px; overflow: hidden;
                                margin: -540px auto;">
                                <img data-class="fadeInDown" id="s10img4" class="border" src="img/screenshot/Younes-pg5-2.png"
                                    imgwidth="890" imgheight="1234" style="position: relative; margin: 0 auto; display: none" />
                            </div>
                        </div>-->
                        <div style="margin: 0 auto; width:670px;">
                        <div id="s10table1" style="position: absolute; width: 685px; display: none; margin-top: 50px;">
                            <table style="width: 98%; max-height: 550px" class="imagTab" cellpadding="10px">
                                <tr>
                                    <td style="width: 50%; text-align: center;">
                                        <img data-class="fadeInDown" onclick="callImageZoom(this)" src="img/Screenshot/saftya.png"
                                            id="s10img1" style="width: 56%" />
                                    </td>
                                    <td style="width: 50%; text-align: center;">
                                        <img onclick="callImageZoom(this)" data-class="fadeInDown" src="img/Screenshot/saftyb.png"
                                            id="s10img2" style="width: 56%" />
                                    </td>
                                </tr>
                                <tr>
                                    <td style="width: 50%; text-align: center;">
                                        <img data-class="fadeInDown" onclick="callImageZoom(this)" src="img/Screenshot/Younes-pg4-2.png"
                                            id="s10img3" style="width: 56%" />
                                    </td>
                                    <!--<td style="width: 50%; text-align: center;">
                                        <img data-class="fadeInDown" onclick="callImageZoom(this)" src="img/screenshot/Younes-pg5-2.png"
                                            id="s10img4" style="width: 56%" />
                                    </td>-->
                                </tr>
                            </table>
                        </div>
                        </div>
                        <div class="zoomedDiv" style="text-align: center; position: relative; display: none;
                            margin-top: 50px;">
                            <span id='imgZoom'><span class="helper"></span>
                                <img id="zoomShowImg" style="height: 545px; padding: 10px; margin: 0 auto;" />
                                <button type="button" onclick="$(this).parent().parent().hide();" class="btn btn-primary"
                                    style="position: absolute; margin-top: -50px; z-index: 100; right: 0; margin-right: 20px;">
                                    Close</button>
                            </span>
                        </div>
                    </div>
                    <!--Transcript -->
                    <div onclick="onclickShowTranscription(this);" id="stickyContent" style="display: none;
                        position: absolute; right: 0; margin-top: 184px;">
                        <a href="#">
                            <img src="../common/img/showTrans.png" /></a>
                    </div>
                    <div id="transcript-hide" style="display: none;">
                        <center>
                            <button type="button" class="hidebutton" onclick="onclickHideTranscription(this);">
                                Hide Transcript</button></center>
                        <div class="transcript">
                            <p>
                                All patients received at least one infusion of brentuximab vedotin. The median number
                                of cycles was 9, the mean number of cycles was 10, and the median relative dose-intensity
                                was 96%.
                            </p>
                            <p>
                                The most common treatment-related adverse events were peripheral sensory neuropathy,
                                nausea, fatigue, neutropenia, diarrhoea, pyrexia, vomiting, arthralgia, pruritus,
                                myalgia, peripheral motor neuropathy and alopecia.
                            </p>
                            <p>
                                55% of the patients experienced adverse events of grade 3 or higher severity.
                            </p>
                            <p>
                                20 patients had adverse events that led to discontinuation of treatment.
                            </p>
                            <p>
                                47% patients had delayed doses of brentuximab vedotin due to adverse events. The
                                most common events leading to dose delays were neutropenia and peripheral sensory
                                neuropathy.
                            </p>
                            <p>
                                Besides peripheral sensory neuropathy, the majority of grade 3 or higher adverse
                                events were laboratory abnormalities including neutropenia, thrombocytopenia, and
                                anaemia.
                            </p>
                            <p>
                                The median time to onset of peripheral neuropathy events was 12.4 weeks and there
                                were no grade 4 peripheral neuropathy events.
                            </p>
                            <p>
                                Eighty percent of patients had either resolution or improvement of peripheral neuropathy
                                and complete resolution of all events of peripheral neuropathy occurred in 50% of
                                patients.
                            </p>
                            <p>
                                The median time to improvement or resolution of peripheral neuropathy was 13.2 weeks.
                            </p>
                        </div>
                    </div>
                    <div id="slide10ref" style="display: none" class="slide10ref">
                        <b>References:</b><br />
                        <br />
                        Results of a Pivotal Phase II Study of Brentuximab Vedotin for Patients With Relapsed
                        or Refractory Hodgkin’s Lymphoma. Younes et al. Journal Of Clinical Oncology. June
                        2012.
                    </div>
                </div>
                <!--slide 10 ending-->
                <div id="slide11" style="display: none;">
                    <!--  <div class="topic-bar">
                    <div id="topic-title">HL: Staging</div>
                </div>-->
                    <div class="slidecontent" style="">
                        <!-- <div id="popupDiv0" class="popupView" style="display: none;">
                            <div style="width: 100%; height: 100%; border-radius: 10px; box-shadow: 1px 1px 7px 0px rgba(0, 0, 0, 0.67);
                                background-color: rgba(255, 255, 255, 0.95); padding-top: 20px;">
                                <div class="fadeInDown" style="display: none; margin-top: 10px;" id="s11bimg2">
                                    <img src="../common/img/bullet01.png" class="noStyle" style="width: 12px; height: 12px;
                                        float: left; margin: 10px;" />
                                    <p style="padding-left: 40px;">
                                        The median duration of therapy was 9 cycles
                                    </p>
                                </div>
                                <div class="fadeInDown" style="display: none; margin-top: 10px;" id="s11bimg1">
                                    <img src="../common/img/bullet01.png" class="noStyle" style="width: 12px; height: 12px;
                                        float: left; margin: 10px;" />
                                    <p style="padding-left: 40px;">
                                        75% of patients achieved an objective response and 34% obtained a CR
                                    </p>
                                </div>
                                <div class="fadeInDown" style="display: none; margin-top: 10px;" id="s11bimg3">
                                    <img src="../common/img/bullet01.png" class="noStyle" style="width: 12px; height: 12px;
                                        float: left; margin: 10px;" />
                                    <p style="padding-left: 40px;">
                                        Prior to treatment with brentuximab vedotin 71% of patients did not achieve a CR
                                        or had experienced relapse within 3 months of prior front-line therapy
                                    </p>
                                </div>
                                <div class="fadeInDown" style="display: none; margin-top: 10px;" id="s11bimg4">
                                    <img src="../common/img/bullet01.png" class="noStyle" style="width: 12px; height: 12px;
                                        float: left; margin: 10px;" />
                                    <p style="padding-left: 40px;">
                                        Median time to relapse after prior auto-SCT was 6.7 months
                                    </p>
                                </div>
                                <div class="fadeInDown" style="display: none; margin-top: 10px;" id="s11bimg5">
                                    <img src="../common/img/bullet01.png" class="noStyle" style="width: 12px; height: 12px;
                                        float: left; margin: 10px;" />
                                    <p style="padding-left: 40px;">
                                        In this context, overall response and durable CR with brentuximab vedotin observed
                                        in the trial are notable
                                    </p>
                                </div>
                                <div class="fadeInDown" style="display: none; margin-top: 10px;" id="s11bimg6">
                                    <img src="../common/img/bullet01.png" class="noStyle" style="width: 12px; height: 12px;
                                        float: left; margin: 10px;" />
                                    <p style="padding-left: 40px;">
                                        Results compare favourably with response rates achieved in the Cancer and Leukemia
                                        Group B study with a multi-agent regimen
                                    </p>
                                </div>
                                <div class="fadeInDown" style="display: none; margin-top: 10px;" id="s11bimg7">
                                    <img src="../common/img/bullet01.png" class="noStyle" style="width: 12px; height: 12px;
                                        float: left; margin: 10px;" />
                                    <p style="padding-left: 40px;">
                                        Antitumor activity was obtained without the characteristic toxicity of combination
                                        chemotherapy regimens
                                    </p>
                                </div>
                            </div>
                        </div>-->
                        <div class="playBody">
                            <div style="text-align: center; margin-top: 10px; width: 500px; height: 500px; overflow: hidden;
                                margin: 10px auto;">
                                <img data-class="fadeInDown" id="s11img1" class="border" src="img/Screenshot/conclusion.png"
                                    imgwidth="890" imgheight="1234" style="position: relative; margin: 0 auto; display: none" />
                            </div>
                        </div>
                        <div class="playBody">
                            <div style="text-align: center; margin-top: -550px;">
                                <span id='imgZoom11'><span class="helper"></span>
                                    <img data-class="fadeInDown" id="s11imag1" class="border" src="img/Screenshot/conclusion.png"
                                        style="display: none; position: relative; width: 380px; height: 548px; margin: 0 auto;" />
                                </span>
                            </div>
                        </div>
                    </div>
                    <div onclick="onclickShowTranscription(this);" id="stickyContent" style="display: none;
                        position: absolute; right: 0; margin-top: 184px;">
                        <a href="#">
                            <img src="../common/img/showTrans.png" /></a>
                    </div>
                    <div id="transcript-hide" style="display: none;">
                        <center>
                            <button type="button" class="hidebutton" onclick="onclickHideTranscription(this);">
                                Hide Transcript</button></center>
                        <div class="transcript" style="">
                            <p>
                                Brentuximab vedotin was administered for a maximum of 16 cycles in this trial; the
                                actual median and mean durations of treatment were 9 and 10 cycles, respectively.
                            </p>
                            <p>
                                In this pivotal, phase II, trial of brentuximab vedotin monotherapy, 75% of patients
                                achieved an objective response and 34% obtained a CR. Patients had disease that
                                was particularly refractory to prior treatments as evidenced by the fact that 71%
                                of patients did not achieve a CR or had experienced relapse within 3 months of front-line
                                therapy.
                            </p>
                            <p>
                                Furthermore, these patients had a poor prognosis because the median time to relapse
                                after auto-SCT was only 6.7 months. In this context, the rates of overall response
                                and durable CR are notable for a single-agent therapy after the failure of prior
                                combination chemotherapy and auto-SCT.
                            </p>
                            <p>
                                These results compare favourably with response rates achieved in the Cancer and
                                Leukemia Group B study of the multiagent regimen of gemcitabine, vinorelbine, and
                                pegylated liposomal doxorubicin in patients with disease relapse after auto-SCT.
                            </p>
                            <p>
                                More than one third of patients achieved a CR with single-agent brentuximab vedotin,
                                and the antitumor activity was obtained without the characteristic toxicity of combination
                                chemotherapy regimens such as gemcitabine, vinorelbine, and pegylated liposomal
                                doxorubicin.
                            </p>
                        </div>
                    </div>
                    <div id="slide11ref" style="display: none" class="slide11ref">
                        <b>References:</b><br />
                        <br />
                        Results of a Pivotal Phase II Study of Brentuximab Vedotin for Patients With Relapsed
                        or Refractory Hodgkin’s Lymphoma. Younes et al. Journal Of Clinical Oncology. June
                        2012.
                    </div>
                </div>
                <div id="slide11a" style="display: none;">
                    <!-- <div class="topic-bar">
                        <div id="topic-title">HL: survival rates</div>
                    </div>-->
                    <!--Body -->
                    <div class="slidecontent" style="">
                        <div class="playBody">
                            <div class="fadeInDown" style="display: none" id="s11abimg1">
                                <p class="breakout" style="padding-left: 40px;">
                                    Brentuximab Vedotin (SGN-35) in Patients With Relapsed or Refractory Systemic Anaplastic
                                    Large-Cell Lymphoma: Results of a Phase II Study. Pro et al. Journal Of Clinical
                                    Oncology. June 2012
                                </p>
                            </div>
                        </div>
                    </div>
                    <!--Transcript -->
                    <div onclick="onclickShowTranscription(this);" id="stickyContent" style="display: none;
                        position: absolute; right: 0; margin-top: 184px;">
                        <a href="#">
                            <img src="../common/img/showTrans.png" /></a>
                    </div>
                    <div id="transcript-hide" style="display: none;">
                        <center>
                            <button type="button" class="hidebutton" onclick="onclickHideTranscription(this);">
                                Hide Transcript</button></center>
                        <div class="transcript">
                            The following part of the module will discuss the key points of the paper titled
                            'Brentuximab vedotin (SGN-35) in Patients with Relapsed or Refractory Systemic Anaplastic
                            Large-cell Lymphoma: Results of a Phase II Study'.
                        </div>
                    </div>
                    <div id="slide11aref" style="display: none;" class="slide11aref">
                        <b>References:</b><br />
                        <br />
                        Brentuximab Vedotin (SGN-35) in Patients With Relapsed or Refractory Systemic Anaplastic
                        Large-Cell Lymphoma: Results of a Phase II Study. Pro et al. Journal Of Clinical
                        Oncology. June 2012.
                    </div>
                </div>
                <div id="slide12" style="display: none;">
                    <!--  <div class="topic-bar">
                    <div id="topic-title">Introduction</div>
                </div>-->
                    <div class="slidecontent" style="">
                        <div class="playBody">
                            <div style="text-align: center; margin-top: 10px; width: 400px; height: 500px; overflow: hidden;
                                margin: 10px auto;">
                                <img data-class="fadeInDown" id="s12img1" class="border" src="img/Screenshot/shot1.png"
                                    imgwidth="890" imgheight="1234" style="position: relative; margin: 0 auto; display: none" />
                            </div>
                        </div>
                        <div class="playBody">
                            <div style="text-align: center; margin-top: -550px;">
                                <span id='imgZoom12'><span class="helper"></span>
                                    <img data-class="fadeInDown" id="img12" class="border" src="img/Screenshot/shot1.png"
                                        style="display: none; position: relative; width: 380px; height: 548px; margin: 0 auto;" />
                                </span>
                            </div>
                        </div>
                    </div>
                    <div onclick="onclickShowTranscription(this);" id="stickyContent" style="display: none;
                        position: absolute; right: 0; margin-top: 184px;">
                        <a href="#">
                            <img src="../common/img/showTrans.png" /></a>
                    </div>
                    <div id="transcript-hide" style="display: none;">
                        <center>
                            <button type="button" class="hidebutton" onclick="onclickHideTranscription(this);">
                                Hide Transcript</button></center>
                        <div class="transcript" style="">
                            <p>
                                Systemic anaplastic large-cell lymphoma (ALCL) is an aggressive subtype of T-cell
                                lymphoma representing approximately 2% to 3% of all lymphoid neoplasms.
                            </p>
                            <p>
                                With the exception of low intermediate-risk ALK-positive patients, patients with
                                ALCL have a poor prognosis when treated with conventional anthracycline-based front-line
                                chemotherapy.
                            </p>
                        </div>
                    </div>
                    <div id="slide12ref" style="display: none" class="slide12ref">
                        <b>References:</b><br />
                        <br />
                        Brentuximab Vedotin (SGN-35) in Patients With Relapsed or Refractory Systemic Anaplastic
                        Large-Cell Lymphoma: Results of a Phase II Study. Pro et al. Journal Of Clinical
                        Oncology. June 2012.
                    </div>
                </div>
                <div id="slide13" style="display: none;">
                    <!--  <div class="topic-bar">
                    <div id="topic-title">Need for a new standard of care</div>
                </div>-->
                    <div class="slidecontent" style="">
                        <div class="playBody">
                            <div style="text-align: center; margin-top: 10px; width: 550px; height: 500px; overflow: hidden;
                                margin: 10px auto;">
                                <img data-class="fadeInDown" id="s13img1" class="border" src="img/Screenshot/shot2.png"
                                    imgwidth="890" imgheight="1234" style="position: relative; margin: 0 auto; display: none" />
                            </div>
                        </div>
                        <div class="playBody">
                            <div style="text-align: center; margin-top: -550px;">
                                <span id='imgZoom13'><span class="helper"></span>
                                    <img data-class="fadeInDown" id="img13" class="border" src="img/Screenshot/shot2.png"
                                        style="display: none; position: relative; width: 380px; height: 548px; margin: 0 auto;" />
                                </span>
                            </div>
                        </div>
                    </div>
                    <div onclick="onclickShowTranscription(this);" id="stickyContent" style="display: none;
                        position: absolute; right: 0; margin-top: 184px;">
                        <a href="#">
                            <img src="../common/img/showTrans.png" /></a>
                    </div>
                    <div id="transcript-hide" style="display: none;">
                        <center>
                            <button type="button" class="hidebutton" onclick="onclickHideTranscription(this);">
                                Hide Transcript</button></center>
                        <div class="transcript" style="">
                            <p>
                                Approximately 40% to 65% of patients with ALCL develop recurrent disease after front-line
                                therapy. ALCL is historically resistant to conventional chemotherapy regimens, and
                                lacks an established standard of care.
                            </p>
                            <p>
                                High-dose therapy and autologous hematopoietic stem-cell transplantation (SCT) may
                                result in long-term remission in 30% to 40% of patients, but the benefit is limited
                                to patients with chemotherapy-sensitive disease and patients without advanced age
                                or co-morbidities
                            </p>
                        </div>
                    </div>
                    <div id="slide13ref" style="display: none" class="slide13ref">
                        <b>References:</b><br />
                        <br />
                        Brentuximab Vedotin (SGN-35) in Patients With Relapsed or Refractory Systemic Anaplastic
                        Large-Cell Lymphoma: Results of a Phase II Study. Pro et al. Journal Of Clinical
                        Oncology. June 2012.
                    </div>
                </div>
                <div id="slide14" style="display: none;">
                    <!--  <div class="topic-bar">
                    <div id="topic-title">HL: prognosis (early disease)</div>
                </div>-->
                    <div class="slidecontent" style="">
                    <div style="margin: 0 auto; width:670px;">
                        <div id="popupDiv14" class="popupView" style="display: none;">
                            <div style="width: 100%; height: 107%; border-radius: 10px; box-shadow: 1px 1px 7px 0px rgba(0, 0, 0, 0.67);
                                background-color: rgba(255, 255, 255, 0.95);">
                                <div class="fadeInDown" style="display: none; margin: 10px; width: 175px; float: left"
                                    id="s3img2">
                                    <img src="img/HL/figure_1.png" class="noStyle" style="width: 165px; height: 173px;
                                        position: relative; float: left;" />
                                    <p style="font-family: Verdana; font-size: 11px;">
                                        1. The antibody in brentuximab vedotin binds to CD30 on the cell surface and delivers
                                        drug to CD30+ cells
                                    </p>
                                </div>
                                <div class="fadeInDown" style="display: none; margin: 10px; width: 175px; float: left"
                                    id="s3img3">
                                    <img src="img/HL/figure_2.png" class="noStyle" class="noStyle" style="width: 165px;
                                        height: 173px; position: relative;" />
                                    <p style="font-family: Verdana; font-size: 11px;">
                                        2. Internalization and lysosomal migration results in enzymatic cleavage of the
                                        ADC to release the cytotoxic agent to the point of action
                                    </p>
                                </div>
                                <div class="fadeInDown" style="display: none; margin: 10px; width: 175px; float: left"
                                    id="s3img4">
                                    <img src="img/HL/figure_3.png" class="noStyle" class="noStyle" style="width: 165px;
                                        height: 173px; position: relative;" />
                                    <p style="font-family: Verdana; font-size: 11px;">
                                        3. Microtubular disruption and apoptosis
                                    </p>
                                </div>
                                <!-- <button id="Button1" type="button" class="btn btn-primary" style="display: none; margin-right: 16px; position: absolute; right: 0; bottom: 0; margin-bottom: 14px;"
                                    onclick="$(this).parent().parent().hide();">
                                    close
                                </button>-->
                            </div>
                        </div>
                        </div>
                        <div class="playBody">
                            <div style="text-align: center; margin-top: 10px; width: 600px; height: 500px; overflow: hidden;
                                margin: 10px auto;">
                                <img data-class="fadeInDown" id="s14img1" class="border" src="img/Screenshot/shot3.png"
                                    imgwidth="890" imgheight="1234" style="position: relative; margin: 0 auto; display: none" />
                            </div>
                        </div>
                        <div class="playBody">
                            <div style="text-align: center; margin-top: -550px;">
                                <span id='imgZoom14'><span class="helper"></span>
                                    <img data-class="fadeInDown" id="img14" class="border" src="img/Screenshot/shot3.png"
                                        style="display: none; position: relative; width: 380px; height: 548px; margin: 0 auto;" />
                                </span>
                            </div>
                        </div>
                    </div>
                    <div onclick="onclickShowTranscription(this);" id="stickyContent" style="display: none;
                        position: absolute; right: 0; margin-top: 184px;">
                        <a href="#">
                            <img src="../common/img/showTrans.png" /></a>
                    </div>
                    <div id="transcript-hide" style="display: none;">
                        <center>
                            <button type="button" class="hidebutton" onclick="onclickHideTranscription(this);">
                                Hide Transcript</button></center>
                        <div class="transcript" style="">
                            <p>
                                Brentuximab vedotin (SGN-35) is an Antibody-drug conjugates (ADC) comprising an
                                anti-CD30 antibody conjugated by a protease cleavable linker to the potent antimicrotubule
                                agent, monomethylauristatin E (MMAE).
                            </p>
                            <p>
                                Antibody-drug conjugates (ADCs) enable the delivery of a cytotoxic drug to the target
                                malignant cell.
                            </p>
                            <p>
                                Binding of the ADC to CD30 on the cell surface initiates internalization of the
                                ADC-CD30 complex, which then traffics to the lysosomal compartment, releasing MMAE
                                via proteolytic cleavage.
                            </p>
                            <p>
                                Binding of MMAE to tubulin disrupts the microtubule network, induces cell cycle
                                arrest.
                            </p>
                            <p>
                                Finally, this results in the death of the CD30-expressing tumour cell by a process
                                of programmed cell death otherwise called apoptosis.
                            </p>
                        </div>
                    </div>
                    <div id="slide14ref" style="display: none" class="slide14ref">
                        <b>References:</b><br />
                        <br />
                        Brentuximab Vedotin (SGN-35) in Patients With Relapsed or Refractory Systemic Anaplastic
                        Large-Cell Lymphoma: Results of a Phase II Study. Pro et al. Journal Of Clinical
                        Oncology. June 2012.
                    </div>
                </div>
                <div id="slide15" style="display: none;">
                    <!--  <div class="topic-bar">
                    <div id="topic-title">Patients and methods</div>
                </div>-->
                    <div class="slidecontent" style="">
                        <div class="playBody">
                            <div style="text-align: center; margin-top: 10px; width: 700px; height: 500px; overflow: hidden;
                                margin: 10px auto;">
                                <img data-class="fadeInDown" id="s15img1" class="border" src="img/Screenshot/shot4.png"
                                    imgwidth="890" imgheight="1234" style="position: relative; margin: 0 auto; display: none" />
                            </div>
                        </div>
                        <div class="playBody">
                            <div style="text-align: center; margin-top: -550px;">
                                <span id='imgZoom15'><span class="helper"></span>
                                    <img data-class="fadeInDown" id="img15" class="border" src="img/Screenshot/shot4.png"
                                        style="display: none; position: relative; width: 380px; height: 548px; margin: 0 auto;" />
                                </span>
                            </div>
                        </div>
                    </div>
                    <div onclick="onclickShowTranscription(this);" id="stickyContent" style="display: none;
                        position: absolute; right: 0; margin-top: 184px;">
                        <a href="#">
                            <img src="../common/img/showTrans.png" /></a>
                    </div>
                    <div id="transcript-hide" style="display: none;">
                        <center>
                            <button type="button" class="hidebutton" onclick="onclickHideTranscription(this);">
                                Hide Transcript</button></center>
                        <div class="transcript" style="">
                            <p>
                                Subjects enrolled in the trial had a diagnosis of relapsed or refractory systemic
                                ALCL after treatment failure of at least one prior therapy with curative intent.
                            </p>
                            <p>
                                The most common prior treatment regimen observed was a combination of cyclophosphamide,
                                doxorubicin, vincristine, and prednisone.
                            </p>
                        </div>
                    </div>
                    <div id="slide15ref" style="display: none" class="slide15ref">
                        <b>References:</b><br />
                        <br />
                        Brentuximab Vedotin (SGN-35) in Patients With Relapsed or Refractory Systemic Anaplastic
                        Large-Cell Lymphoma: Results of a Phase II Study. Pro et al. Journal Of Clinical
                        Oncology. June 2012.
                    </div>
                </div>
                <div id="slide16" style="display: none;">
                    <!--  <div class="topic-bar">
                    <div id="topic-title">Treatment and assessment</div>
                </div>-->
                    <div class="slidecontent" style="">
                        <div class="playBody">
                            <div style="text-align: center; margin-top: 10px; width: 700px; height: 500px; overflow: hidden;
                                margin: 10px auto;">
                                <img data-class="fadeInDown" id="s16img1" class="border" src="img/Screenshot/shot7.png"
                                    imgwidth="890" imgheight="1234" style="position: relative; margin: 0 auto; display: none" />
                            </div>
                        </div>
                        <div class="playBody">
                            <div style="text-align: center; margin-top: -550px;">
                                <span id='imgZoom16'><span class="helper"></span>
                                    <img data-class="fadeInDown" id="img16" class="border" src="img/Screenshot/shot7.png"
                                        style="display: none; position: relative; width: 380px; height: 548px; margin: 0 auto;" />
                                </span>
                            </div>
                        </div>
                    </div>
                    <div onclick="onclickShowTranscription(this);" id="stickyContent" style="display: none;
                        position: absolute; right: 0; margin-top: 184px;">
                        <a href="#">
                            <img src="../common/img/showTrans.png" /></a>
                    </div>
                    <div id="transcript-hide" style="display: none;">
                        <center>
                            <button type="button" class="hidebutton" onclick="onclickHideTranscription(this);">
                                Hide Transcript</button></center>
                        <div class="transcript" style="">
                            <p>
                                Brentuximab vedotin 1.8 mg/kg was administered intravenously once every 3 weeks
                                over 30 minutes on an outpatient basis for up to 16 total doses.
                            </p>
                            <p>
                                Both investigators and an independent review facility performed response assessments
                                according to the Revised Response Criteria for Malignant Lymphoma using clinical
                                and imaging assessments.
                            </p>
                        </div>
                    </div>
                    <div id="slide16ref" style="display: none" class="slide16ref">
                        <b>References:</b><br />
                        <br />
                        Brentuximab Vedotin (SGN-35) in Patients With Relapsed or Refractory Systemic Anaplastic
                        Large-Cell Lymphoma: Results of a Phase II Study. Pro et al. Journal Of Clinical
                        Oncology. June 2012.
                    </div>
                </div>
                <div id="slide17" style="display: none;">
                    <!--  <div class="topic-bar">
                    <div id="topic-title">Patient characteristics</div>
                </div>-->
                    <div class="slidecontent" style="">
                        <div class="playBody">
                            <div style="text-align: center; margin-top: 10px; width: 700px; height: 500px; overflow: hidden;
                                margin: 10px auto;">
                                <img data-class="fadeInDown" id="s17img1" class="border" src="img/Screenshot/shot6.png"
                                    imgwidth="890" imgheight="1234" style="position: relative; margin: 0 auto; display: none" />
                            </div>
                        </div>
                        <div class="playBody">
                            <div style="text-align: center; margin-top: -550px;">
                                <span id='imgZoom17'><span class="helper"></span>
                                    <img data-class="fadeInDown" id="img17" class="border" src="img/Screenshot/shot6.png"
                                        style="display: none; position: relative; width: 380px; height: 548px; margin: 0 auto;" />
                                </span>
                            </div>
                        </div>
                        <div class="playBody">
                            <div style="text-align: center; margin-top: 10px;">
                                <img data-class="fadeInDown" id="s17img1" class="border" src="img/ALCLscreenshot/screenshot_6.png"
                                    style="display: none; width: 390px;" />
                            </div>
                            <div style="text-align: center; margin-top: 10px;">
                                <img data-class="fadeInDown" id="s17img2" class="border" src="img/ALCLscreenshot/screenshot_7.png"
                                    style="display: none; width: 450px;" />
                            </div>
                            <div data-class="fadeInDown" id="s17bimg1" style="display: none;">
                                <img src="../common/img/bullet01.png" class="noStyle" style="width: 12px; height: 12px;
                                    float: left; margin: 10px;" />
                                <p style="margin-top: 20px;">
                                    26% had post SCT treatment failure before enrolment
                                </p>
                            </div>
                        </div>
                    </div>
                    <div onclick="onclickShowTranscription(this);" id="stickyContent" style="display: none;
                        position: absolute; right: 0; margin-top: 184px;">
                        <a href="#">
                            <img src="../common/img/showTrans.png" /></a>
                    </div>
                    <div id="transcript-hide" style="display: none;">
                        <center>
                            <button type="button" class="hidebutton" onclick="onclickHideTranscription(this);">
                                Hide Transcript</button></center>
                        <div class="transcript" style="">
                            <p>
                                Of the total patients with prior therapy 50% of patients experienced relapse and
                                50% were considered refractory; 62% of patients were primary refractory to front-line
                                treatment.
                            </p>
                            <p>
                                26% of patients experienced treatment failure with an autologous SCT before study
                                enrolment.
                            </p>
                        </div>
                    </div>
                    <div id="slide17ref" style="display: none" class="slide17ref">
                        <b>References:</b><br />
                        <br />
                        Brentuximab Vedotin (SGN-35) in Patients With Relapsed or Refractory Systemic Anaplastic
                        Large-Cell Lymphoma: Results of a Phase II Study. Pro et al. Journal Of Clinical
                        Oncology. June 2012.
                    </div>
                </div>
                <div id="slide17a" style="display: none;">
                    <!-- <div class="topic-bar">
                        <div id="topic-title">HL: survival rates</div>
                    </div>-->
                    <!--Body -->
                    <div class="slidecontent" style="">
                        <div class="playBody">
                            <div style="padding-left: 20px">
                                <br />
                                <p data-class="fadeInDown" style="display: none;" id="s17atxt1">
                                    The most common prior treatment regimen among patients in this study was
                                </p>
                                <br />
                                <input type="hidden" id="Answer" value="2" qid="3"/>
                                <input type="hidden" id="Percentage" value="25" />
                                <div id="radio1" style="padding: 10px 25px 10px 10px; display: none;">
                                    <input name="ratio1" value="1" type="radio" style="width: 2em; height: 1.5em; float: left;" />
                                    <p data-class="fadeInRight" style="padding-left: 55px;">
                                        Cyclophosphamide, doxorubicin, vincristine, etoposide, and prednisone (CHOEP)</p>
                                </div>
                                <div id="radio2" style="padding: 10px 25px 10px 10px; display: none;">
                                    <input name="ratio1" value="2" type="radio" style="width: 2em; height: 1.5em; float: left;" />
                                    <p data-class="fadeInRight" style="padding-left: 55px;">
                                        Cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP)</p>
                                </div>
                                <div id="radio3" style="padding: 10px 25px 10px 10px; display: none;">
                                    <input name="ratio1" value="3" type="radio" style="width: 2em; height: 1.5em; float: left;" />
                                    <p data-class="fadeInRight" style="padding-left: 55px;">
                                        Cyclophosphamide, doxorubicin, vincristine, and dexamethasone</p>
                                </div>
                                <div id="radio4" style="padding: 10px 25px 10px 10px; display: none;">
                                    <input name="ratio1" value="4" type="radio" style="width: 2em; height: 1.5em; float: left;" />
                                    <p data-class="fadeInRight" style="padding-left: 55px;">
                                        Etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin</p>
                                </div>
                                <div style="margin-left: 470px;">
                                    <div>
                                        <input id="s17aimag9" onclick="onclickAnswer(this);" type="button" class="btn btn-primary"
                                            value="Submit" style="width: 100px; margin-right: 25px; display: none" />
                                    </div>
                                    <br />
                                </div>
                            </div>
                        </div>
                    </div>
                    <!--Transcript -->
                    <div onclick="onclickShowTranscription(this);" id="stickyContent" style="display: none;
                        position: absolute; right: 0; margin-top: 184px;">
                        <a href="#">
                            <img src="../common/img/showTrans.png" /></a>
                    </div>
                    <div id="transcript-hide" style="display: none;">
                        <center>
                            <button type="button" class="hidebutton" onclick="onclickHideTranscription(this);">
                                Hide Transcript</button></center>
                        <div class="transcript">
                            <br />
                            Please take a moment to answer a question. Please select the best answer and click
                            submit to continue.
                        </div>
                    </div>
                    <div id="slide17aref" style="display: none;" class="slide17aref">
                        <b>References:</b><br />
                        <br />
                        Results of a Pivotal Phase II Study of Brentuximab Vedotin for Patients With Relapsed
                        or Refractory Hodgkin’s Lymphoma. Younes et al. Journal Of Clinical Oncology. June
                        2012.
                    </div>
                </div>
                <!--slide 17a ending-->
                <div id="slide18" style="display: none;">
                    <!--  <div class="topic-bar">
                    <div id="topic-title">Response to treatment</div>
                </div>-->
                    <div class="slidecontent" style="">
                        <div class="playBody">
                            <div style="text-align: center; margin-top: 10px; width: 700px; height: 500px; overflow: hidden;
                                margin: 10px auto;">
                                <img data-class="fadeInDown" id="s18img1" class="border" src="img/Screenshot/shot9.png"
                                    imgwidth="890" imgheight="1234" style="position: relative; margin: 0 auto; display: none" />
                            </div>
                        </div>
                        <div class="playBody">
                            <div style="text-align: center; margin-top: -550px;">
                                <span id='imgZoom18'><span class="helper"></span>
                                    <img data-class="fadeInDown" id="img18" class="border" src="img/Screenshot/shot9.png"
                                        style="display: none; position: relative; width: 380px; height: 548px; margin: 0 auto;" />
                                </span>
                            </div>
                        </div>
                        <div class="playBody">
                            <div style="height: 100%">
                                <div style="height: 400px;">
                                    <div style="text-align: center; margin-top: 10px;">
                                        <img data-class="fadeInDown" id="s18img1" class="border" src="img/ALCLscreenshot/screenshot_8.png"
                                            style="display: none; width: 395px;" />
                                    </div>
                                    <div style="text-align: center; margin-top: 10px;">
                                        <img data-class="fadeInDown" id="s18img2" class="border" src="img/ALCLscreenshot/screenshot_9.png"
                                            style="display: none; width: 415px;" />
                                    </div>
                                </div>
                                <div style="height: 50%;">
                                    <div data-class="fadeInDown" id="s18bimg1" style="display: none; margin-top: 40px;">
                                        <img src="../common/img/bullet01.png" class="noStyle" style="width: 12px; height: 12px;
                                            float: left; margin: 10px;" />
                                        <p>
                                            The objective response rate (ORR) was 86%
                                        </p>
                                    </div>
                                    <div data-class="fadeInDown" id="s18bimg2" style="display: none;">
                                        <img src="../common/img/bullet01.png" class="noStyle" style="width: 12px; height: 12px;
                                            float: left; margin: 10px;" />
                                        <p>
                                            57% of patients achieved complete response (CR)
                                        </p>
                                    </div>
                                    <div data-class="fadeInDown" id="s18bimg3" style="display: none;">
                                        <img src="../common/img/bullet01.png" class="noStyle" style="width: 12px; height: 12px;
                                            float: left; margin: 10px;" />
                                        <p>
                                            29% achieved partial remission
                                        </p>
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                    <div onclick="onclickShowTranscription(this);" id="stickyContent" style="display: none;
                        position: absolute; right: 0; margin-top: 184px;">
                        <a href="#">
                            <img src="../common/img/showTrans.png" /></a>
                    </div>
                    <div id="transcript-hide" style="display: none;">
                        <center>
                            <button type="button" class="hidebutton" onclick="onclickHideTranscription(this);">
                                Hide Transcript</button></center>
                        <div class="transcript" style="">
                            <p>
                                The objective response rate (ORR) per independent review was 86%. 57% of patients
                                achieved complete response (CR), and 29% achieved partial remission.
                            </p>
                            <p>
                                Tumour reductions were observed in 97% of patients.
                            </p>
                        </div>
                    </div>
                    <div id="slide18ref" style="display: none" class="slide18ref">
                        <b>References:</b><br />
                        <br />
                        Brentuximab Vedotin (SGN-35) in Patients With Relapsed or Refractory Systemic Anaplastic
                        Large-Cell Lymphoma: Results of a Phase II Study. Pro et al. Journal Of Clinical
                        Oncology. June 2012.
                    </div>
                </div>
                <div id="slide19" style="display: none;">
                    <!--  <div class="topic-bar">
                    <div id="topic-title">Duration of response</div>
                </div>-->
                    <div class="slidecontent" style="">
                        <div class="playBody">
                            <div style="text-align: center; margin-top: 10px; width: 500px; height: 500px; overflow: hidden;
                                margin: 10px auto;">
                                <img data-class="fadeInDown" id="s19imag1" class="border" src="img/Screenshot/shot10.png"
                                    imgwidth="890" imgheight="1234" style="position: relative; margin: 0 auto; display: none" />
                            </div>
                        </div>
                        <div class="playBody">
                            <div style="text-align: center; margin-top: 10px; width: 500px; height: 500px; overflow: hidden;
                                margin: -540px auto;">
                                <img data-class="fadeInDown" id="s19imag2" class="border" src="img/Screenshot/shot11.png"
                                    imgwidth="890" imgheight="1234" style="position: relative; margin: 0 auto; display: none" />
                            </div>
                        </div>
                        <div style="margin: 0 auto; width:670px;">
                        <div id="s19table1" style="position: absolute; width: 685px; display: none;">
                            <table style="width: 98%;" class="imagTab" cellpadding="10px">
                                <tr>
                                    <td style="width: 50%;">
                                        <img data-class="fadeInDown" onclick="callImageZoom(this)" src="img/Screenshot/shot10.png"
                                            id="s19imag1" style="width: 100%" />
                                    </td>
                                    <td style="width: 50%;">
                                        <img onclick="callImageZoom(this)" data-class="fadeInDown" src="img/Screenshot/shot11.png"
                                            id="s19imag2" style="width: 100%" /></td>
                                </tr>
                            </table>
                        </div>
                        </div>
                        <div class="zoomedDiv" style="text-align: center; position: relative; display: none;">
                            <span id='imgZoom'><span class="helper"></span>
                                <img id="zoomShowImg" style="height: 545px; padding: 10px; margin: 0 auto;" />
                                <button type="button" onclick="$(this).parent().parent().hide();" class="btn btn-primary"
                                    style="position: absolute; margin-top: -50px; z-index: 100; right: 0; margin-right: 20px;">
                                    Close</button>
                            </span>
                        </div>
                        <div class="playBody">
                            <div style="text-align: center; margin-top: 10px;">
                                <img data-class="fadeInDown" id="img1" class="border" src="img/ALCLscreenshot/screenshot_10.png"
                                    style="display: none; width: 450px;" />
                            </div>
                            <div data-class="fadeInDown" id="bimg1" style="display: none;">
                                <img src="../common/img/bullet01.png" class="noStyle" style="width: 12px; height: 12px;
                                    float: left; margin: 10px;" />
                                <p>
                                    Median duration of objective response rate (ORR) was 12.6 months
                                </p>
                            </div>
                            <div data-class="fadeInDown" id="bimg2" style="display: none;">
                                <img src="../common/img/bullet01.png" class="noStyle" style="width: 12px; height: 12px;
                                    float: left; margin: 10px;" />
                                <p>
                                    The median duration of response for patients who achieved a CR was 13.2 months
                                </p>
                            </div>
                            <div style="text-align: center; margin-top: 10px;">
                                <img data-class="fadeInDown" id="img2" class="border" src="img/ALCLscreenshot/screenshot_11.png"
                                    style="display: none; width: 450px;" />
                            </div>
                        </div>
                    </div>
                    <div onclick="onclickShowTranscription(this);" id="stickyContent" style="display: none;
                        position: absolute; right: 0; margin-top: 184px;">
                        <a href="#">
                            <img src="../common/img/showTrans.png" /></a>
                    </div>
                    <div id="transcript-hide" style="display: none;">
                        <center>
                            <button type="button" class="hidebutton" onclick="onclickHideTranscription(this);">
                                Hide Transcript</button></center>
                        <div class="transcript" style="">
                            <p>
                                The median duration of objective response reported in the study was 12.6 months.
                            </p>
                            <p>
                                The median duration of response for patients who achieved a CR was 13.2 months.
                            </p>
                            <p>
                                For the 22 patients who achieved a CR and did not have a subsequent SCT, the median
                                duration of response was 12.6 months, compared with a median of 13.2 months for
                                the six patients who had a subsequent allogeneic SCT in CR.
                            </p>
                        </div>
                    </div>
                    <div id="slide19ref" style="display: none" class="slide19ref">
                        <b>References:</b><br />
                        <br />
                        Brentuximab Vedotin (SGN-35) in Patients With Relapsed or Refractory Systemic Anaplastic
                        Large-Cell Lymphoma: Results of a Phase II Study. Pro et al. Journal Of Clinical
                        Oncology. June 2012.
                    </div>
                </div>
                <div id="slide20" style="display: none;">
                    <!--  <div class="topic-bar">
                    <div id="topic-title">Overall survival and progression free survival</div>
                </div>-->
                    <div class="slidecontent" style="">
                        <div class="playBody">
                            <div style="text-align: center; margin-top: 10px; width: 500px; height: 500px; overflow: hidden;
                                margin: 10px auto;">
                                <img data-class="fadeInDown" id="s20imag1" class="border" src="img/Screenshot/Pro_sALCL-s28-1.png"
                                    imgwidth="890" imgheight="1234" style="position: relative; margin: 0 auto; display: none" />
                            </div>
                        </div>
                        <div class="playBody">
                            <div style="text-align: center; margin-top: 10px; width: 500px; height: 500px; overflow: hidden;
                                margin: -540px auto;">
                                <img data-class="fadeInDown" id="s20imag2" class="border" src="img/Screenshot/Pro_sALCL-s28-2.png"
                                    imgwidth="890" imgheight="1234" style="position: relative; margin: 0 auto; display: none" />
                            </div>
                        </div>
                        <div style="margin: 0 auto; width:670px;">
                        <div id="s20table1" style="position: absolute; width: 685px; display: none;">
                            <table style="width: 98%;" class="imagTab" cellpadding="10px">
                                <tr>
                                    <td style="width: 50%;">
                                        <img data-class="fadeInDown" onclick="callImageZoom(this)" src="img/Screenshot/Pro_sALCL-s28-1.png"
                                            id="s20imag1" style="width: 100%" />
                                    </td>
                                    <td style="width: 50%;">
                                        <img onclick="callImageZoom(this)" data-class="fadeInDown" src="img/Screenshot/Pro_sALCL-s28-2.png"
                                            id="s20imag2" style="width: 100%" /></td>
                                </tr>
                            </table>
                        </div>
                        </div>
                        <div class="zoomedDiv" style="text-align: center; position: relative; display: none;">
                            <span id='imgZoom'><span class="helper"></span>
                                <img id="zoomShowImg" style="height: 545px; padding: 10px; margin: 0 auto;" />
                                <button type="button" onclick="$(this).parent().parent().hide();" class="btn btn-primary"
                                    style="position: absolute; margin-top: -50px; z-index: 100; right: 0; margin-right: 20px;">
                                    Close</button>
                            </span>
                        </div>
                        <div class="playBody">
                            <div style="text-align: center; margin-top: 10px;">
                                <img data-class="fadeInDown" id="s20img1" src="img/3.png" class="noStyle" style="display: none;" />
                            </div>
                            <div id="s20hdn1">
                                <div data-class="fadeInDown" id="bimg1" style="display: none; margin-top: 10px;">
                                    <img src="../common/img/bullet01.png" class="noStyle" style="width: 12px; height: 12px;
                                        float: left; margin: 10px;" />
                                    <p>
                                        Median overall survival not reached
                                    </p>
                                </div>
                                <div data-class="fadeInDown" id="bimg2" style="display: none;">
                                    <img src="../common/img/bullet01.png" class="noStyle" class="bullet" style="width: 12px;
                                        height: 12px; float: left; margin: 10px;" />
                                    <p>
                                        The estimated 12-month survival rate was 70%
                                    </p>
                                </div>
                                <div data-class="fadeInDown" id="bimg3" style="display: none;">
                                    <img src="../common/img/bullet01.png" class="noStyle" style="width: 12px; height: 12px;
                                        float: left; margin: 10px;" />
                                    <p>
                                        Median progression free survival 13.3 months
                                    </p>
                                </div>
                                <div data-class="fadeInDown" id="bimg4" style="display: none;">
                                    <img src="../common/img/bullet01.png" class="noStyle" style="width: 12px; height: 12px;
                                        float: left; margin: 10px;" />
                                    <p>
                                        Comparable response rates in patients with ALK positive and ALK negative disease
                                    </p>
                                </div>
                            </div>
                            <div data-class="fadeInDown" id="bimg5" style="display: none; margin-top: 10px;">
                                <img src="../common/img/bullet01.png" class="noStyle" style="width: 12px; height: 12px;
                                    float: left; margin: 10px;" />
                                <p>
                                    ORR in ALK -ve was 88% and ALK +ve was 81%
                                </p>
                            </div>
                            <div data-class="fadeInDown" id="bimg6" style="display: none;">
                                <img src="../common/img/bullet01.png" class="noStyle" style="width: 12px; height: 12px;
                                    float: left; margin: 10px;" />
                                <p>
                                    CR in ALK -ve was 52% and ALK +ve was 69%
                                </p>
                            </div>
                        </div>
                    </div>
                    <div onclick="onclickShowTranscription(this);" id="stickyContent" style="display: none;
                        position: absolute; right: 0; margin-top: 184px;">
                        <a href="#">
                            <img src="../common/img/showTrans.png" /></a>
                    </div>
                    <div id="transcript-hide" style="display: none;">
                        <center>
                            <button type="button" class="hidebutton" onclick="onclickHideTranscription(this);">
                                Hide Transcript</button></center>
                        <div class="transcript" style="">
                            <p>
                                At the time of the analysis 18 patients had died and median overall survival (OS)
                                was not reached.
                            </p>
                            <p>
                                The estimated 12-month survival rate was 70%.
                            </p>
                            <p>
                                Median progression-free survival (PFS) among all patients was 13.3 months.
                            </p>
                            <p>
                                Among patients with ALK-negative disease, the ORR was 88%, and the CR rate was 52%.
                                These response rates were comparable to those among patients with ALK-positive disease,
                                who had an ORR of 81% and a CR rate of 69%. Median PFS and duration of response
                                were not different between patients with ALK-negative disease and patients with
                                ALK-positive disease.
                            </p>
                        </div>
                    </div>
                    <div id="slide20ref" style="display: none" class="slide20ref">
                        <b>References:</b><br />
                        <br />
                        Brentuximab Vedotin (SGN-35) in Patients With Relapsed or Refractory Systemic Anaplastic
                        Large-Cell Lymphoma: Results of a Phase II Study. Pro et al. Journal Of Clinical
                        Oncology. June 2012.
                    </div>
                </div>
                <div id="slide21" style="display: none;">
                    <!--  <div class="topic-bar">
                    <div id="topic-title">Comparison of response with brentuximab vedotin with prior therapy</div>
                </div>-->
                    <div class="slidecontent" style="">
                        <div class="playBody">
                            <div style="text-align: center; margin-top: 10px; width: 400px; height: 500px; overflow: hidden;
                                margin: 10px auto;">
                                <img data-class="fadeInDown" id="s21img1" class="border" src="img/Screenshot/shot17.png"
                                    imgwidth="890" imgheight="1234" style="position: relative; margin: 0 auto; display: none" />
                            </div>
                        </div>
                        <div class="playBody">
                            <div style="text-align: center; margin-top: -550px;">
                                <span id='imgZoom21'><span class="helper"></span>
                                    <img data-class="fadeInDown" id="img21" class="border" src="img/Screenshot/shot17.png"
                                        style="display: none; position: relative; width: 380px; height: 548px; margin: 0 auto;" />
                                </span>
                            </div>
                        </div>
                        <div class="playBody">
                            <div style="text-align: center; margin-top: 10px;">
                                <img data-class="fadeInDown" id="img1" class="border" src="img/ALCLscreenshot/screenshot_13.png"
                                    style="display: none;" />
                            </div>
                            <div data-class="fadeInDown" id="bimg1" style="display: none; margin-top: 10px;">
                                <img src="../common/img/bullet01.png" class="noStyle" style="width: 12px; height: 12px;
                                    float: left; margin: 10px;" />
                                <p>
                                    Median PFS with brentuximab vedotin 14.3 months
                                </p>
                            </div>
                            <div data-class="fadeInDown" id="bimg2" style="display: none;">
                                <img src="../common/img/bullet01.png" class="noStyle" style="width: 12px; height: 12px;
                                    float: left; margin: 10px;" />
                                <p>
                                    Median PFS after most recent prior therapy 5.9 months
                                </p>
                            </div>
                        </div>
                    </div>
                    <div onclick="onclickShowTranscription(this);" id="stickyContent" style="display: none;
                        position: absolute; right: 0; margin-top: 184px;">
                        <a href="#">
                            <img src="../common/img/showTrans.png" /></a>
                    </div>
                    <div id="transcript-hide" style="display: none;">
                        <center>
                            <button type="button" class="hidebutton" onclick="onclickHideTranscription(this);">
                                Hide Transcript</button></center>
                        <div class="transcript" style="">
                            <p>
                                Median progression free survival (PFS) with brentuximab vedotin was 14.3 months
                                compared with a median PFS of 5.9 months after the most recent prior therapy, including
                                autologous SCT.
                            </p>
                            <p>
                                The PFS was significantly prolonged with brentuximab vedotin compared with the most
                                recent prior therapy.
                            </p>
                        </div>
                    </div>
                    <div id="slide21ref" style="display: none" class="slide21ref">
                        <b>References:</b><br />
                        <br />
                        Brentuximab Vedotin (SGN-35) in Patients With Relapsed or Refractory Systemic Anaplastic
                        Large-Cell Lymphoma: Results of a Phase II Study. Pro et al. Journal Of Clinical
                        Oncology. June 2012.
                    </div>
                </div>
                <div id="slide22" style="display: none;">
                    <!--  <div class="topic-bar">
                    <div id="topic-title">Safety</div>
                </div>-->
                    <div class="slidecontent" style="">
                        <div class="playBody">
                            <div style="text-align: center; margin-top: 10px; width: 500px; height: 500px; overflow: hidden;
                                margin: 10px auto;">
                                <img data-class="fadeInDown" id="s22imag1" class="border" src="img/Screenshot/shot13.png"
                                    imgwidth="890" imgheight="1234" style="position: relative; margin: 0 auto; display: none" />
                            </div>
                        </div>
                        <div class="playBody">
                            <div style="text-align: center; margin-top: 10px; width: 500px; height: 500px; overflow: hidden;
                                margin: -540px auto;">
                                <img data-class="fadeInDown" id="s22imag2" class="border" src="img/Screenshot/shot14.png"
                                    imgwidth="890" imgheight="1234" style="position: relative; margin: 0 auto; display: none" />
                            </div>
                        </div>
                        <div style="margin: 0 auto; width:670px;">
                        <div id="s22table1" style="position: absolute; width: 685px; display: none;">
                            <table style="width: 98%;" class="imagTab" cellpadding="10px">
                                <tr>
                                    <td style="width: 50%;">
                                        <img data-class="fadeInDown" onclick="callImageZoom(this)" src="img/Screenshot/shot13.png"
                                            id="s22imag1" style="width: 100%" />
                                    </td>
                                    <td style="width: 50%;">
                                        <img onclick="callImageZoom(this)" data-class="fadeInDown" src="img/Screenshot/shot14.png"
                                            id="s22imag2" style="width: 100%" /></td>
                                </tr>
                            </table>
                        </div>
                        </div>
                        <div class="zoomedDiv" style="text-align: center; position: relative; display: none;">
                            <span id='imgZoom'><span class="helper"></span>
                                <img id="zoomShowImg" style="height: 545px; padding: 10px; margin: 0 auto;" />
                                <button type="button" onclick="$(this).parent().parent().hide();" class="btn btn-primary"
                                    style="position: absolute; margin-top: -50px; z-index: 100; right: 0; margin-right: 20px;">
                                    Close</button>
                            </span>
                        </div>
                        <div class="playBody">
                            <div style="height: 100%;">
                                <div style="height: 300px;">
                                    <div id="s22hdn1">
                                        <div style="text-align: center; margin-top: 10px;">
                                            <img data-class="fadeInDown" id="s22img1" class="border" src="img/ALCLscreenshot/screenshot_14.png"
                                                style="display: none; width: 400px;" />
                                        </div>
                                        <div style="text-align: center; margin-top: 10px;">
                                            <img data-class="fadeInDown" id="s22img2" class="border" src="img/ALCLscreenshot/screenshot_15.png"
                                                style="display: none; width: 400px;" />
                                        </div>
                                    </div>
                                    <div style="text-align: center; margin-top: 10px;">
                                        <img data-class="fadeInDown" id="s22img3" class="border" src="img/ALCLscreenshot/screenshot_16.png"
                                            style="display: none; width: 400px;" />
                                    </div>
                                    <div style="text-align: center; margin-top: 10px;">
                                        <img data-class="fadeInDown" id="s22img4" class="border" src="img/ALCLscreenshot/screenshot_18.png"
                                            style="display: none; width: 400px;" />
                                    </div>
                                    <div style="text-align: center; margin-top: 10px;">
                                        <img data-class="fadeInDown" id="s22img5" class="border" src="img/ALCLscreenshot/screenshot_19.png"
                                            style="display: none; width: 400px;" />
                                    </div>
                                </div>
                                <div style="height: 50%;">
                                    <div id="s22hdn2">
                                        <div data-class="fadeInDown" id="s22bimg1" style="display: none; margin-top: -50px;">
                                            <img src="../common/img/bullet01.png" class="noStyle" style="width: 12px; height: 12px;
                                                float: left; margin: 10px;" />
                                            <p>
                                                The median number of cycles for all patients was 7
                                            </p>
                                        </div>
                                        <div data-class="fadeInDown" id="s22bimg2" style="display: none;">
                                            <img src="../common/img/bullet01.png" class="noStyle" style="width: 12px; height: 12px;
                                                float: left; margin: 10px;" />
                                            <p>
                                                The median number of cycles for responding patients was 8
                                            </p>
                                        </div>
                                        <div data-class="fadeInDown" id="s22bimg3" style="display: none;">
                                            <img src="../common/img/bullet01.png" class="noStyle" style="width: 12px; height: 12px;
                                                float: left; margin: 10px;" />
                                            <p>
                                                Grade 3 or higher AEs in 60% of the patients
                                            </p>
                                        </div>
                                    </div>
                                    <div data-class="fadeInDown" id="s22bimg4" style="display: none;">
                                        <img src="../common/img/bullet01.png" class="noStyle" style="width: 12px; height: 12px;
                                            float: left; margin: 10px;" />
                                        <p>
                                            6 deaths occurred within 30 days of the last administration of brentuximab vedotin
                                        </p>
                                    </div>
                                    <div data-class="fadeInDown" id="s22bimg5" style="display: none;">
                                        <img src="../common/img/bullet01.png" class="noStyle" style="width: 12px; height: 12px;
                                            float: left; margin: 10px;" />
                                        <p>
                                            None attributed to study drug
                                        </p>
                                    </div>
                                    <div data-class="fadeInDown" id="s22bimg6" style="display: none;">
                                        <img src="../common/img/bullet01.png" class="noStyle" style="width: 12px; height: 12px;
                                            float: left; margin: 10px;" />
                                        <p>
                                            Adverse events led to treatment discontinuation in 14 patients
                                        </p>
                                    </div>
                                    <div data-class="fadeInDown" id="s22bimg7" style="display: none;">
                                        <img src="../common/img/bullet01.png" class="noStyle" style="width: 12px; height: 12px;
                                            float: left; margin: 10px;" />
                                        <p>
                                            Adverse events led to treatment delay in 40% of patients and the most common were
                                            peripheral sensory neuropathy and neutropenia
                                        </p>
                                    </div>
                                    <div data-class="fadeInDown" id="s22bimg8" style="display: none;">
                                        <img src="../common/img/bullet01.png" class="noStyle" style="width: 12px; height: 12px;
                                            float: left; margin: 10px;" />
                                        <p>
                                            The median time to improvement or resolution of peripheral neuropathy was 9.9 weeks
                                        </p>
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                    <div onclick="onclickShowTranscription(this);" id="stickyContent" style="display: none;
                        position: absolute; right: 0; margin-top: 184px;">
                        <a href="#">
                            <img src="../common/img/showTrans.png" /></a>
                    </div>
                    <div id="transcript-hide" style="display: none;">
                        <center>
                            <button type="button" class="hidebutton" onclick="onclickHideTranscription(this);">
                                Hide Transcript</button></center>
                        <div class="transcript" style="">
                            <p>
                                All patients enrolled onto this study received at least one dose of brentuximab
                                vedotin. The median number of cycles was 7 and among patients with an objective
                                response, the median number of cycles was 8.
                            </p>
                            <p>
                                The most common adverse events of any grade, regardless of relationship to brentuximab
                                vedotin, were peripheral sensory neuropathy, nausea, fatigue, pyrexia, diarrhoea,
                                rash, constipation and neutropenia.
                            </p>
                            <p>
                                Neutropenia, thrombocytopenia, peripheral sensory neuropathy and anaemia were the
                                most common among events of grade 3 or higher severity that occurred in the study.
                            </p>
                            <p>
                                Adverse events of grade 3 or higher severity were experienced by 60% of the patients.
                            </p>
                            <p>
                                Six deaths occurred within 30 days of the last administration of brentuximab vedotin
                                and none of these deaths were attributed to study drug. Four of the deaths were
                                attributed to disease recurrence.
                            </p>
                            <p>
                                Adverse events led to treatment discontinuation in 14 patients and peripheral sensory
                                neuropathy was the only adverse event that resulted in treatment discontinuation
                                in more than one patient.
                            </p>
                            <p>
                                Doses of brentuximab vedotin were delayed because of adverse events in 40% of patients;
                                however, only 10% of doses were delayed overall. The most common events leading
                                to dose delays were peripheral sensory neuropathy and neutropenia.
                            </p>
                            <p>
                                The median time to onset of peripheral neuropathy events was 13.3 weeks and the
                                median time to improvement or resolution of peripheral neuropathy was 9.9 weeks.
                            </p>
                            <p>
                                Resolution or some improvement in peripheral neuropathy was observed in 81% of patients.
                                Complete resolution of all events was achieved in 48% of patients.
                            </p>
                        </div>
                    </div>
                    <div id="slide22ref" style="display: none" class="slide22ref">
                        <b>References:</b><br />
                        <br />
                        Brentuximab Vedotin (SGN-35) in Patients With Relapsed or Refractory Systemic Anaplastic
                        Large-Cell Lymphoma: Results of a Phase II Study. Pro et al. Journal Of Clinical
                        Oncology. June 2012.
                    </div>
                </div>
                <div id="slide22a" style="display: none;">
                    <!-- <div class="topic-bar">
                        <div id="topic-title">HL: survival rates</div>
                    </div>-->
                    <!--Body -->
                    <div class="slidecontent" style="">
                        <div class="playBody">
                            <div style="padding-left: 20px">
                                <br />
                                <p data-class="fadeInDown" style="display: none;" id="s22atxt1">
                                    The most common adverse events of grade 3 or higher severity that occurred in the
                                    study were
                                </p>
                                <br />
                                <input type="hidden" id="Answer" value="3" qid="4"/>
                                <input type="hidden" id="Percentage" value="25" />
                                <div id="radio1" style="padding: 10px 25px 10px 10px; display: none;">
                                    <input name="ratio2" value="1" type="radio" style="width: 2em; height: 1.5em; float: left;" />
                                    <p data-class="fadeInRight" style="padding-left: 55px;">
                                        Peripheral sensory neuropathy,nausea and fatigue</p>
                                </div>
                                <div id="radio2" style="padding: 10px 25px 10px 10px; display: none;">
                                    <input name="ratio2" value="2" type="radio" style="width: 2em; height: 1.5em; float: left;" />
                                    <p data-class="fadeInRight" style="padding-left: 55px;">
                                        Pyrexia, diarrhoea, rash, constipation and neutropenia</p>
                                </div>
                                <div id="radio3" style="padding: 10px 25px 10px 10px; display: none;">
                                    <input name="ratio2" value="3" type="radio" style="width: 2em; height: 1.5em; float: left;" />
                                    <p data-class="fadeInRight" style="padding-left: 55px;">
                                        Neutropenia, thrombocytopenia, peripheral sensory neuropathy and anaemia</p>
                                </div>
                                <div id="radio4" style="padding: 10px 25px 10px 10px; display: none;">
                                    <input name="ratio2" value="4" type="radio" style="width: 2em; height: 1.5em; float: left;" />
                                    <p data-class="fadeInRight" style="padding-left: 55px;">
                                        Neutropenia, thrombocytopenia, peripheral sensory nausea, and fatigue</p>
                                </div>
                                <div style="margin-left: 470px;">
                                    <div>
                                        <input id="s22aimag9" onclick="onclickAnswer(this);" type="button" class="btn btn-primary"
                                            value="Submit" style="width: 100px; margin-right: 25px; display: none" />
                                    </div>
                                    <br />
                                </div>
                            </div>
                        </div>
                    </div>
                    <!--Transcript -->
                    <div onclick="onclickShowTranscription(this);" id="stickyContent" style="display: none;
                        position: absolute; right: 0; margin-top: 184px;">
                        <a href="#">
                            <img src="../common/img/showTrans.png" /></a>
                    </div>
                    <div id="transcript-hide" style="display: none;">
                        <center>
                            <button type="button" class="hidebutton" onclick="onclickHideTranscription(this);">
                                Hide Transcript</button></center>
                        <div class="transcript">
                            <br />
                            Please take a moment to answer a question. Please select the best answer and click
                            submit to continue.
                        </div>
                    </div>
                    <div id="slide22aref" style="display: none;" class="slide22aref">
                        <b>References:</b><br />
                        <br />
                        Results of a Pivotal Phase II Study of Brentuximab Vedotin for Patients With Relapsed
                        or Refractory Hodgkin’s Lymphoma. Younes et al. Journal Of Clinical Oncology. June
                        2012.
                    </div>
                </div>
                <!--slide 22a ending-->
                <div id="slide23" style="display: none;">
                    <!--  <div class="topic-bar">
                    <div id="topic-title">Discussion</div>
                </div>-->
                    <div class="slidecontent" style="">
                        <div class="playBody">
                            <div style="text-align: center; margin-top: 10px; width: 500px; height: 500px; overflow: hidden;
                                margin: 10px auto;">
                                <img data-class="fadeInDown" id="s23imag1" class="border" src="img/Screenshot/shot15.png"
                                    imgwidth="890" imgheight="1234" style="position: relative; margin: 0 auto; display: none" />
                            </div>
                        </div>
                        <div class="playBody">
                            <div style="text-align: center; margin-top: 10px; width: 500px; height: 500px; overflow: hidden;
                                margin: -540px auto;">
                                <img data-class="fadeInDown" id="s23imag2" class="border" src="img/Screenshot/shot16.png"
                                    imgwidth="890" imgheight="1234" style="position: relative; margin: 0 auto; display: none" />
                            </div>
                        </div>
                        <div style="margin: 0 auto; width:670px;">
                        <div id="s23table1" style="position: absolute; width: 685px; display: none;">
                            <table style="width: 98%;" class="imagTab" cellpadding="10px">
                                <tr>
                                    <td style="width: 50%;">
                                        <img data-class="fadeInDown" onclick="callImageZoom(this)" src="img/Screenshot/shot15.png"
                                            id="s23imag1" style="width: 100%" />
                                    </td>
                                    <td style="width: 50%;">
                                        <img onclick="callImageZoom(this)" data-class="fadeInDown" src="img/Screenshot/shot16.png"
                                            id="s23imag2" style="width: 100%" /></td>
                                </tr>
                            </table>
                        </div>
                        </div>
                        <div class="zoomedDiv" style="text-align: center; position: relative; display: none;">
                            <span id='imgZoom'><span class="helper"></span>
                                <img id="zoomShowImg" style="height: 545px; padding: 10px; margin: 0 auto;" />
                                <button type="button" onclick="$(this).parent().parent().hide();" class="btn btn-primary"
                                    style="position: absolute; margin-top: -50px; z-index: 100; right: 0; margin-right: 20px;">
                                    Close</button>
                            </span>
                        </div>
                        <div class="playBody">
                            <div style="height: 100%;">
                                <div style="height: 300px;">
                                    <div id="s23hdn1">
                                        <div style="text-align: center; margin-top: 10px;">
                                            <img data-class="fadeInDown" id="s23img1" class="border" src="img/ALCLscreenshot/screenshot_20.png"
                                                style="display: none; width: 450px;" />
                                        </div>
                                    </div>
                                    <div style="text-align: center; margin-top: 10px;">
                                        <img data-class="fadeInDown" id="s23img2" class="border" src="img/ALCLscreenshot/screenshot_21.png"
                                            style="display: none; width: 400px;" />
                                    </div>
                                    <div style="text-align: center; margin-top: 10px;">
                                        <img data-class="fadeInDown" id="s23img3" class="border" src="img/ALCLscreenshot/screenshot_23.png"
                                            style="display: none; width: 450px;" />
                                    </div>
                                    <div style="text-align: center; margin-top: 10px;">
                                        <img data-class="fadeInDown" id="s23img4" class="border" src="img/ALCLscreenshot/screenshot_24.png"
                                            style="display: none; width: 450px;" />
                                    </div>
                                    <div style="text-align: center; margin-top: 10px;">
                                        <img data-class="fadeInDown" id="s23img5" class="border" src="img/ALCLscreenshot/screenshot_25.png"
                                            style="display: none;" />
                                    </div>
                                </div>
                                <div style="height: 50%;">
                                    <div id="s23hdn5">
                                        <div data-class="fadeInDown" id="s23bimg1" style="display: none;">
                                            <img src="../common/img/bullet01.png" class="noStyle" style="width: 12px; height: 12px;
                                                float: left; margin: 10px;" />
                                            <p style="margin-top: 90px;">
                                                86% objective response and 57% complete response
                                            </p>
                                        </div>
                                        <div data-class="fadeInDown" id="s23bimg2" style="display: none;">
                                            <img src="../common/img/bullet01.png" class="noStyle" style="width: 12px; height: 12px;
                                                float: left; margin: 10px;" />
                                            <p style="">
                                                The median duration of objective response was 12.6 months
                                            </p>
                                        </div>
                                        <div data-class="fadeInDown" id="s23bimg3" style="display: none;">
                                            <img src="../common/img/bullet01.png" class="noStyle" style="width: 12px; height: 12px;
                                                float: left; margin: 10px;" />
                                            <p style="">
                                                97% of patients achieved tumor reduction
                                            </p>
                                        </div>
                                    </div>
                                    <div data-class="fadeInDown" id="s23bimg5" style="display: none;">
                                        <img src="../common/img/bullet01.png" class="noStyle" style="width: 12px; height: 12px;
                                            float: left; margin: 10px;" />
                                        <p style="margin-top: 50px;">
                                            The improvements were independent of ALK status or number of prior therapies
                                        </p>
                                    </div>
                                    <div data-class="fadeInDown" id="s23bimg4" style="display: none;">
                                        <img src="../common/img/bullet01.png" class="noStyle" style="width: 12px; height: 12px;
                                            float: left; margin: 10px;" />
                                        <p style="">
                                            70% of patients were alive 1 year after the initiation of treatment, with the medial
                                            overall survival not yet reached
                                        </p>
                                    </div>
                                    <div data-class="fadeInDown" id="s23bimg6" style="display: none; margin-top: 20px;">
                                        <img src="../common/img/bullet01.png" class="noStyle" style="width: 12px; height: 12px;
                                            float: left; margin: 10px;" />
                                        <p style="">
                                            Most common adverse events were constitutional in nature except peripheral sensory
                                            neuropathy
                                        </p>
                                    </div>
                                    <div data-class="fadeInDown" id="s23bimg7" style="display: none;">
                                        <img src="../common/img/bullet01.png" class="noStyle" style="width: 12px; height: 12px;
                                            float: left; margin: 10px;" />
                                        <p style="">
                                            Study results validate a CD30-targeted approach in a disease with uniform antigen
                                            expression
                                        </p>
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                    <div onclick="onclickShowTranscription(this);" id="stickyContent" style="display: none;
                        position: absolute; right: 0; margin-top: 184px;">
                        <a href="#">
                            <img src="../common/img/showTrans.png" /></a>
                    </div>
                    <div id="transcript-hide" style="display: none;">
                        <center>
                            <button type="button" class="hidebutton" onclick="onclickHideTranscription(this);">
                                Hide Transcript</button></center>
                        <div class="transcript" style="">
                            <p>
                                In this trial, which was the largest prospective trial reported in patients with
                                recurrent systemic ALCL, a majority of patients responded to treatment.
                            </p>
                            <p>
                                Objective responses were observed in 86% of patients and 57% of patients achieved
                                a CR
                            </p>
                            <p>
                                Responses generally occurred within 6 weeks of treatment initiation the median duration
                                of response was greater than 1 year
                            </p>
                            <p>
                                97% of patients achieved tumour reduction, and disease-related signs and symptoms
                                whenever present at baseline resolved during treatment.
                            </p>
                            <p>
                                The improvements were independent of ALK status or number of prior therapies, suggesting
                                that responses observed with brentuximab vedotin are not limited to a specific subgroup
                                of patients.
                            </p>
                            <p>
                                Despite the high percentage of patients with refractory disease, 70% of patients
                                were alive 1 year after the initiation of treatment, with the median overall survival
                                not yet reached.
                            </p>
                            <p>
                                After achieving remission with brentuximab vedotin in this study, 16 patients received
                                an autologous or allogeneic SCT with the intent of securing a long-term remission.
                            </p>
                            <p>
                                At the time of this analysis, response durations among these patients were similar,
                                regardless of subsequent transplantation. A sensitivity analysis of PFS of the patients
                                with transplantation and that of the pre-specified analysis revealed that the median
                                PFS was equivalent to the PFS calculated using the pre-specified analysis (13.3
                                months), indicating that the analyses performed in the study were robust.
                            </p>
                            <p>
                                The most common adverse events in the study were generally constitutional in nature,
                                with the exception of peripheral sensory neuropathy.
                            </p>
                            <p>
                                The study results validate a CD-30 targeted approach in a disease with uniform antigen
                                expression.
                            </p>
                        </div>
                    </div>
                    <div id="slide23ref" style="display: none" class="slide23ref">
                        <b>References:</b><br />
                        <br />
                        Brentuximab Vedotin (SGN-35) in Patients With Relapsed or Refractory Systemic Anaplastic
                        Large-Cell Lymphoma: Results of a Phase II Study. Pro et al. Journal Of Clinical
                        Oncology. June 2012.
                    </div>
                </div>
                <div id="slide24" style="display: none;">
                    <!-- <div class="topic-bar">
                        <div id="topic-title">Title</div>
                    </div>-->
                    <!--Body -->
                    <div style="height: 550px; width: 100%; margin: 0px auto; border: 2px solid rgba(127, 145, 145, 0.12);
                        border-radius: 10px; background-color: rgba(255, 255, 255, 0.2);">
                        <div class="playBody">
                            <div data-class="fadeInDown" class="breakout" style="display: none; text-align: center;
                                height: 95px;" id="s24img1">
                                <p class="" style="font-size: 20px; width: 450px; position: relative; text-align: left">
                                    End of Module!
                                </p>
                                <p class="fadeInDown" id="s24img2" style="display: none; text-align: left">
                                    Please close the window and attempt the post-test in order to complete the course.
                                </p>
                            </div>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </div>
    <div id="footer" style="width: 1024px; margin: 0 auto;">
        <div class="container" style="">
            <table style="width: 100%">
                <tr>
                    <td>
                        <img src="../common/img/takeda.png" style="float: left; width: 105px; margin-top: 3px;
                            margin-right: 10px; margin-left: -25px;" />
                    </td>
                    <td>
                        <img onmouseover="HideToolTip(this)" data-toggle="tooltip" title="Play / Pause" class="effect"
                            id="toggelbutton" class="effect" src="../common/img/playBtn.png" style="float: left;
                            margin-top: -10px;" onclick="play()" />
                    </td>
                    <td>
                        <div style="float: left;">
                            <input id="progress-bar" type="text" data-slider="true" data-slider-highlight="true">
                            <div class="slider-control">
                                <span id="slideCount">Slide 0 of 00</span> <span style="float: right;"><span id="timeduration">
                                    0:00</span> / <span id="slideduration">0:00</span></span>
                            </div>
                        </div>
                    </td>
                    <td>
                        <img onmouseover="HideToolTip(this)" data-toggle="tooltip" data-placement="left"
                            title="Previous Slide " class="effect" src="../common/img/prevBtn.png" style="margin-top: -10px;"
                            onclick="Prev()" />
                    </td>
                    <td>
                        <img onmouseover="HideToolTip(this)" id="NxtImg" data-toggle="tooltip" title="Next Slide"
                            class="effect" src="../common/img/nxtBtn.png" style="margin-top: -10px;" onclick="Next()" />
                    </td>
                    <td>
                        <img onclick="ShowHelp();" id="showHelp" src="../common/img/smallicon2.png" style="margin-top: -10px;
                            margin-left: 35px;" />
                    </td>
                    <td>
                        <a href="pdf/Transcript_Module_07_ver_1.00.pdf" target="_blank">
                            <img onmouseover="HideToolTip(this)" data-toggle="tooltip" title="Print" class="effect"
                                src="../common/img/smallicon3.png" style="margin-top: -10px;" /></a>
                    </td>
                </tr>
            </table>
            <!--  <img class="effect" src="../common/img/pauseBtn.png" style="float: left; margin-top: -10px;" onclick="pause()" />-->
        </div>
    </div>
    <div class="modal fade" id="AnswerModal" data-backdrop="static" tabindex="-1" role="dialog"
        aria-labelledby="myModalLabel" aria-hidden="true">
        <div class="modal-dialog">
            <div class="modal-content">
                <div class="modal-body">
                </div>
                <div class="modal-footer">
                    <button type="button" onclick="onclickAnswerContinue()" class="btn btn-primary">
                        Continue</button>
                </div>
            </div>
        </div>
    </div>

    <script>
        $('img').tooltip({ trigger: "focus" });
    </script>

</body>
</html>
